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Ischemic disease leads to increased tissue stress by decreasing supply of nutrients 
adequate to meet energy demands.  To maintain functionality, compensatory 
mechanisms for diminished vascular supply are induced by numerous tissues factors 
associated with ischemia.  Compensatory responses include both remodeling of the 
vascular network to sustain substrate delivery and adaptive responses within affected 
tissue to sustain function despite diminished substrate availability.  Active aerobic 
exercise has been shown to improve both vascular and metabolic remodeling within and 
around ischemic tissues.  However, active exercise programs, while consistently 
beneficial, still generate a very heterogeneous response, suggesting the potential for an 
important contribution from the genetic composition determining intrinsic aerobic 
exercise capacity.  A novel rat strain, developed using forced artificial selection for 
intrinsic endurance running capacity, provides a unique tool that enables assessment of 
intrinsic aerobic capacity and the effects of these phenotypes on adaptive responses to 
ischemic stress. Untrained low endurance running capacity (LCR) rats were found to 
have a higher incidence of risk factors for ischemic disease and may have differing 
vascular and metabolic responses to peripheral artery occlusion. The overall goal of this 
dissertation was to determine the influence of intrinsic exercise capacity on the vascular 
and metabolic adaptive responses to ischemic stress. This study tested the hypothesis that 
the LCR would show altered vascular and metabolic adaptive responses in response to 
 peripheral arterial occlusion, compared to HCR counterparts.  Muscle samples from 
both the ischemic and the non-ischemic limb in both strains were compared metabolically 
for their relative capacity to oxidize fatty acid, histologically for the anatomical vascular 
capillarity supporting perfusion, and functionally using both perfusion tracers to track 
blood flow, and direct muscle stimulation to test fatigue characteristics. Biomarkers 
obtained using PCR were obtained to suggest potential pathways accounting for 
differences in response between the phenotypes.  Results indicate that intrinsic aerobic 
phenotype does alter both the resting tolerance for demand induced ischemia, as well as 
the adaptive compensatory responses to chronic anatomic arterial obstruction.  The 
LCRs showed both a reduced capacity for demand induced workloads, as well as 
responses to chronic obstruction that were both delayed in onset, and delayed in induction 
compared to HCR counterparts.  These data may have implications for better structuring 
active exercise programs to achieve intended outcomes in limiting consequences 
associated with cardiovascular disease risk factors.  
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 CHAPTER 1:  INTRODUCTION 
 
The underlying basis for ischemic disease, one of the most deadly and costly 
diseases of the Western world, is a mismatch between the oxygen supplied by the 
bloodstream and the oxygen demands of the tissue.  The two predominant forms of 
ischemic disease that affect millions of Americans annually are coronary artery disease 
and peripheral arterial occlusive disease (PAOD)(67; 73; 96; 103).  The American Heart 
Association has found that there are differences between ethnic groups and their 
predisposition for cardiovascular diseases to include susceptibility for ischemic disease 
(85).  This data suggest that there are phenotypic influences on the development for 
ischemic disease and more research may be necessary to better understand how 
phenotype may influence development and progression of disease.  Both cardiac and 
peripheral tissues employ compensatory mechanisms in response to ischemia.  These 
mechanisms primarily include a vascular remodeling process that increases perfusion 
capacity to offset any deficits in supply (61; 62; 80) and remodeling of metabolic 
pathways, including changes in the activity of oxidative enzymes (17; 84) enabling tissue 
to better tolerate chronic deficits in vascular supply.  
The heart is one of the most versatile tissues in the body, capable of utilizing 
multiple substrates to meet energy demands.  Under normal resting conditions, cardiac 
muscle derives approximately 70% of its energy from fatty acid oxidation (34).  
However, fatty acid oxidation depends on a ready supply of oxygen, such that under 
ischemic conditions, as in progressive coronary artery occlusive disease, cardiac 
metabolism shifts towards using more anaerobic glycolytic mechanisms to meet energy 
demands (34).  Unfortunately, the energy yield of glycolysis is insufficient to meet the 
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energy requirements of cardiac demand, and glycolysis produces lactic acid, a potential 
cause of cardiac pain.  It has been suggested that within as little as 30 minutes from the 
onset of acute coronary ischemia, alterations in adenine concentrations and other 
metabolic oxidative stressors can lead to cardiac cell death (88).  Studies of post 
ischemic myocardium have reported that carnitine treatment (19), adenine nucleotide 
reuptake inhibitors (57), malate/aspartate solutions (utilizing transamination pathways) 
(46), glucose/insulin/potassium solutions (89), mitochondrial ATPase targeted drugs (37), 
adenosine (74), and delta opiod agonists (37) all have shown to enhance recovery from 
cardiac ischemic challenges, all at least in part due to effects on metabolic pathways.  
Further complicating the analysis is that, while diabetes is a major risk factor for 
cardiovascular disease, insulin insensitivity is a much less essential component of 
substrate utilization in cardiac muscle (13; 63), leaving open the question regarding 
whether the primary effect of diabetes is directly related to metabolic alterations, or 
secondary to atherosclerotic processes and hypertension, with which diabetes is also 
associated, and to which the heart is highly vulnerable.  The complexity of cardiac 
metabolism suggests that shifting substrate preference is a major component of the 
dynamic response to ischemia (13; 63), perhaps more than oxidative capacity of any 
particular substrate.  When one considers that heart tissue also is much less accessible to 
recurring assessment during chronic conditions, and tissue availability often occurs in the 
setting of an acute critical ischemic event superimposed on the chronic conditions, it 
becomes clear that studying metabolic responses in the heart to challenges such as 
exercise or disease is complex. 
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In peripheral arterial occlusive diseases, which are just as prevalent as coronary 
artery disease, the basic factors that stimulate vascular and metabolic remodeling are the 
same, but the tissue is much more accessible to study, and the metabolic characteristics of 
skeletal muscle fibers are more precisely defined, and significantly less variable than in 
cardiac muscle.  Skeletal muscle responds to arterial insufficiency by generating a 
vascularization stimulus that utilizes the same critical factors to stimulate remodeling as 
cardiac muscle.  However, skeletal muscle also has the ability to alter enzyme activity 
and to change muscle fiber type towards a more anaerobic phenotype (18; 75).   
Regular aerobic active exercise is one of the few interventions that have been 
shown to consistently slow the progression of occlusive arterial diseases, and to enhance 
the recovery from them.  Exercise induces many effects, including lowering serum 
lipids and raising plasma HDL levels (33), both of which are thought to decrease the risk 
of atherosclerosis in most arterial systems (25; 33).  Regular aerobic exercise lowers 
resting blood pressure (48), which limits the resting energetic demands of the heart, and 
limits the progression of atherosclerosis in both cardiac and peripheral locations.  
Regular aerobic exercise increases tissue responsiveness to insulin, and stimulates 
increases in key enzymes regulating metabolic pathways, promoting substrate uptake and 
utilization in peripheral tissues (7; 35), and presumably in cardiac tissue as well.  
Aerobic exercise also increases vascular capillarity (81) and increases vascular 
responsiveness to vasoactive substances such as nitric oxide (23), which serves both to 
increase anatomic flow capacity, as well as dynamic flow responsiveness.  For all that 
has been reported with regard to the benefits of active aerobic exercise, little is known 
about how the intrinsic capacity to exercise, independent from any active exercise 
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component, influences the vascular or metabolic remodeling responses to occlusive 
arterial disease. 
Given the complexities involved in analyzing the metabolic demands of cardiac 
muscle, peripheral ischemia is a more attractive model for investigating how tissues 
respond to ischemic conditions, and has been used extensively for that purpose.  
However, most studies to date have concentrated on studying either the vascular 
component of ischemic disease, or the metabolic component, while few have examined 
the integrated relationship between skeletal muscle capillarity and metabolic adaptations 
to chronic occlusion within the same muscle tissue, and none have done so in the context 
of the intrinsic exercise capacity phenotype.   
Therefore, the aim of this dissertation was to study the influence of intrinsic 
aerobic exercise capacity on vascular and metabolic adaptive responses to ischemic stress, 
and tests the overall hypothesis that the low aerobic endurance running capacity 
(LCR) phenotype will show altered vascular and metabolic adaptive responses to 
peripheral arterial occlusion when compared to the high aerobic endurance running 
capacity (HCR) phenotype. 
Peripheral Arterial Occlusive Disease (PAOD) 
Peripheral artery occlusive disease (PAOD) affects 8-12 million Americans and is 
difficult to treat (67).  It has been suggested that ethnicity plays a role in the 
development of this disease with Blacks and Hispanics having higher risk for 
development compared to Asians and Caucasians(6).  This data suggest that phenotype 
influences the development and progression of ischemic disease. PAOD occurs mainly in 
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the lower extremities, and its incidence and prevalence are nearly equal to that of 
coronary artery disease (103).  Approximately 15% of adults over age 55 have 
detectable hemodynamic impairments attributable to PAOD (103).  There are two major 
clinical presentations of PAOD: intermittent claudication and critical limb ischemia.  
Intermittent claudication presents as pain during exercising conditions when blood flow 
is insufficient to meet tissue demands, but which resolves with time after return to resting 
conditions.  Critical limb ischemia is characterized by blood flow that is inadequate to 
meet demands at resting conditions, leading to leg pain at rest, marked disability, and 
impaired quality of life (103). 
Treatments for PAOD include pharmacological agents that reduce atherosclerotic 
risk-factors, and delay the development of occlusive plaques.  Surgical treatments for 
PAOD include mechanical revascularization, either by percutaneous methods, or by 
direct bypass (103).  Revascularization is an option for advanced disease but is not 
realistic in patients with multiple obstructions (94).  In addition, revascularization 
studies have demonstrated that gender and race are synergistic determinants in vein graft 
failure suggesting that phenotype is an important factor behind PAOD and clinical 
outcomes(69).  Surgical therapy carries a risk of perioperative morbidity and mortality, 
and a large number of patients are unable to undergo surgical therapy.  In addition, 
surgical therapy is not always successful (100).  Occlusions may recur and patients can 
again progress towards pain with walking and other clinical symptoms of PAOD.  New 
and more efficacious treatments options for PAOD clearly are needed. 
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Considering the limits of surgical revascularization as a treatment option, other 
non-invasive treatments that increase perfusion to downstream ischemic tissue are being 
investigated.  Understanding the processes and pathways of capillary and artery 
development in adults is paramount for development of these new therapies, and most 
new experimental treatments emphasize re-establishing perfusion.  Several years ago, 
treatment strategies targeting gene mediated revascularization in PAOD showed initial 
promise in limited clinical trials, but have since not proven consistently efficacious, and 
the basis for the variability in responsiveness was not clear (5; 98).  The working focus 
of experimental and clinical studies in POAD has been on reestablishing perfusion, as 
that is the anatomic deficit.  However, there are no therapies that directly target 
improved function of distal tissues as an alternative, or an adjunct to re-establishing 
vascular supply.  Evidence from aerobic exercise training studies suggested clinical 
PAOD patients increase capillary density and oxidative capacity with time (101; 107), 
but the underlying mechanisms that cause the changes in oxidative capacity in 
conjunction with changes in capillary density is not understood well at this time.  
Research on the adaptive and remodeling characteristics of ischemic tissue may provide 
new cell based treatments for PAOD. 
Hind limb femoral artery ligation is a well-established popular model for the 
study of chronic ischemia and PAOD (70; 100; 103), and provides a relevant conceptual 
framework to assess the pathways of ischemia-induced changes in the vasculature and 
surrounding tissue.  Hind limb femoral artery ligation is an accepted model of 
intermittent claudication, and has been used to study potential mechanism underlying the 
beneficial effects of aerobic exercise training (70; 103).  Recent studies by Lloyd et al. 
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(61; 62), utilized the femoral artery ligation model to assess angiogenic growth factor 
expression in rats in response to a chronic ischemic injury during an active aerobic 
exercise training protocol lasting three weeks (61; 62), reporting that pro-angiogenic gene 
signals were increased significantly within days after occlusion, and that aerobic exercise 
increased the overall capillary remodeling response following occlusion.  Roberts et al. 
(84) utilized this injury model coupled with aerobic exercise training and studied changes 
in oxidative capacity and capillarity in plantaris and soleus muscles, and demonstrated 
that arterial insufficiency caused vascular and metabolic remodeling in both red and 
white skeletal muscles fiber types, and that aerobic exercise training improved upon these 
adaptations (84).  However, the influence of pre-existing intrinsic aerobic exercise 
capacity on these adaptations to ischemia was not established and remains poorly 
understood.  In summary, there is a well-established model for PAOD that has been 
used to study components of vascular and metabolic adaptations occurring in 
skeletal muscle in response to ischemia, and the effects of exercise, that would be 
appropriate for studies of intrinsic aerobic capacity influences. 
Ischemic Induced Adaptations and Remodeling of Skeletal Muscle 
Skeletal muscle responsiveness to ischemia or depletion of oxygen is dependent 
on the muscle fiber type (64).  Skeletal muscle has three distinct fiber types. Slow twitch 
(Type I) fibers have a high concentration of mitochondria and myoglobin (64).  Fast 
twitch fibers (Type II) fibers are subdivided further into two distinct subtypes: Type IIA 
and Type IIB (64).  Type IIA fibers are fast oxidative fibers that exhibit a faster 
contractile velocity than Type I but also contain a high myoglobin and mitochondrial 
content.  Type IIB fibers are fast glycolytic fibers with less myoglobin and fewer 
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mitochondria. Type IIB fibers have a higher storage content of glycogen (64) and rely 
heavily on anaerobic metabolism to meet their energy demands.  Because fiber types 
and their distributions within a muscle are genetically influenced, individuals differ in 
terms of baseline oxygen supply and utilization within a given muscle.  These genetic 
differences in fiber type distribution provide a basis for intrinsic difference in intrinsic 
aerobic exercise capacity. 
In the rat, different skeletal muscles have distinct fiber type populations.  In 
addition, rat skeletal muscle also has a Type IID/X fiber which is similar to other Type II 
or fast twitch fibers in their myosin heavy chain composition but has distinct 
physiological and biochemical properties.  Generally, the deepest extensor muscles have 
the highest percentage of Type I fibers and the lowest percentage of Type IIB fibers (4).  
However, muscle fibers also are capable of transforming from one fiber type extreme to 
another in response to altered functional demands, hormonal signals, or changes in neural 
input (75).  Delp et al. found that both the soleus (84%) and adductor longus (87%) 
muscles contain a high proportion of Type I fibers (24).  The soleus muscle was found 
to have no Type IIB fiber expression.  Different portions of the gastrocnemius contain 
different fiber concentrations.  The gastrocnemius muscle is typically analyzed as red, 
mixed and white sections.  However, the delineation is not as clear as the naming might 
suggest, and indicates only the dominant fiber type.  The red gastrocnemius muscle was 
51% Type I, 35% type IIA, and 14% Type IIB which is still approximately 86% percent 
of this muscle section to be described as oxidative fibers, while the mixed gastrocnemius 
muscle was 1% Type I and 3% Type IIA fibers, and 28% Type IID/X and 68% Type IIB 
fibers.  White gastrocnemius was found to have no Type I or Type IIA fibers (24).  
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Thus the soleus, and white portions of the gastrocnemius muscle appear to be relatively 
homogeneous muscles that correspond to the well defined characteristics of slow 
oxidative, and fast glycolytic fiber classification (24).  This demonstrates that rat 
gastrocnemius muscle provides distinct fiber populations that can allow a deeper 
understanding of how different fibers respond to stressors. 
Skeletal muscle is remarkably adaptable to ischemia and the stress of endurance 
exercise training (Figure 1.1) compensating for reduced oxygen availability by increasing 
mitochondrial volume density (volume of mitochondria per volume of muscle fiber) and 
citrate synthase activity (36; 64; 99).  Ischemic conditions also cause skeletal muscle to 
shift substrate utilization away from fatty acid oxidation towards glucose oxidation, 
which improves the yield of ATP generated per mole of oxygen consumed (40; 64; 87).  
If ischemia persists, skeletal muscle can undergo fiber type switching towards a more 
glycolytic phenotype (Figure 1.1) (75).  This phenotype switch is normally a slow 
twitch to fast twitch fiber switch leading to a decrease in Type I fibers and an increase in 
the Type II fibers (75).  Muscle fibers, once considered a static entity or tissue, are now 
understood to be dynamic structures with extraordinary adaptive potential.  In 
summary skeletal muscle adaptations to ischemic conditions, many of which are at 
least partially transcription dependent phenomena, include changes in substrate 
utilization pathways, oxidative enzyme activities, mitochondrial volume density and, 
if warranted, fiber type phenotypic switching. However, the influence of intrinsic 
aerobic phenotype on these processes is unknown. 
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Skeletal muscle also responds to ischemic challenge via vascular remodeling. In 
response to ischemia, skeletal muscle may increase the expression of vascular endothelial 
growth factor (VEGF) mRNA, which in turn can lead to increases in VEGF protein (18).  
Increased VEGF expression has been shown to ameliorate peripheral blood flow 
insufficiencies and promote angiogenesis (14).  VEGF has also been shown to produce 
dose-dependent release of nitric oxide (NO).  NO, in addition to other factors, including 
VEGF and angiopoietin (Ang) 2, stimulates both angiogenesis and arteriogenesis, 
reflecting the development of new blood vessels, primarily capillaries, and the 
remodeling of existing blood vessels to develop/expand collateral perfusion, respectively.  
Angiogenesis and arteriogenesis are presumed to work in concert, promoting 
opportunities to maintain or sustain bulk flow at an arteriolar level, in concert with 
changes in capillarity that modify residual flow distribution to individual fibers, together 
restoring skeletal muscle perfusion towards baseline conditions and alleviating ischemic 
conditions (90). 
Exercise 
 Understanding the complexities of exercise requires more than discrimination 
between active aerobic exercise training and/or resistance training.  There are two 
distinct entities that contribute to exercise capacity, broadly characterized as genetic and 
environment influences.  The environmental component represents the imposed 
conditions that cause the skeletal muscle to react and adapt, and can be represented by 
such things as diet and exercise training programs. The genetic component relates to the 
genes that regulate intrinsic aerobic exercise capacity and genes that respond to active 
aerobic or resistance training stimuli.  It is thought that 70% of the variation in intrinsic 
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aerobic capacity is determined genetically (9).  A variety of genes may participate in the 
determination of intrinsic aerobic exercise capacity, and these genes are capable of 
influencing every physiological system within the human body. 
Intrinsic Aerobic Exercise Capacity 
Low aerobic capacity, or low cardiorespiratory fitness, is a strong predictor of 
early mortality (97).  Aerobic capacity is determine by a variety of factors that 
encompass both environmental and genetic influences.  Twin and family studies support 
heritability of intrinsic exercise capacity, VO2max, and the inducible aerobic capacity, 
ability to increase VO2max with aerobic exercise training (9). 
It has been difficult to determine the role intrinsic aerobic capacity plays in the 
progression of human disease states because it is nearly impossible to control for 
environmental influences.  Twin studies have provided valuable insight into the way 
genes influence intrinsic exercise capacity (9).  The HERITAGE family study, which 
evaluated VO2max during sedentary and training phases, suggested that there are several 
specific chromosomal regions linked to individual VO2max (8).  These twin and family 
studies have pointed towards 17 mitochondrial genes and 165 autosomal genes that 
appear to influence fitness and performance phenotypes (8).  Within metabolic disease, 
these studies have provided insight into the pathogenesis by demonstrating a down 
regulation in expression of genes involved in aerobic metabolism.  Conversely, these 
markers of aerobic metabolism appear to be upregulated in individuals with increased 
physical capacity.  This literature supports the need for a better understanding of how 
genes influence both intrinsic exercise capacity and the ability to respond to active 
exercise training. 
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It is widely accepted that individuals differ drastically in aerobic capacities in the 
absence of a training stimulus and in their inherent capacity to adapt to exercise (8-10).  
Research clearly shows that individuals with diminished aerobic capacity have increased 
morbidity and decreased quality of life (30; 48; 65).  Genes that enhance intrinsic 
aerobic exercise capacity are believed to provide protection against disease, decrease 
complications associated with disease, and allow the individual to respond favorably to 
different types of stress.  In summary, while clearly present, the genetic influence on 
aerobic capacity largely has been overlooked primarily due to modeling difficulties.  
Aerobic Exercise Training 
Dynamic exercise training has been shown to improve and treat various chronic 
diseases, including coronary heart disease, hypertension, osteoporosis, obesity, and 
metabolic disease (11; 47; 55; 58; 77).  Physiologic adaptations that improve muscle 
function, delivery and use of fuel sources are just a few of the changes associated with 
improved exercise capacity (84).  In ischemic diseases, aerobic exercise training has 
been shown to induce beneficial physiological adaptations both prior to symptoms of 
disease onset, and also in advanced disease states. 
The physiological adaptations associated with aerobic exercise training include 
both metabolic and vascular adaptations within skeletal muscle. Aerobic exercise training 
has been shown to stimulate increases in angiogenic and arteriogenic pathways that lead 
to tissue remodeling and better perfusion of the tissue (81; 82).  This remodeling has 
been shown to alleviate symptoms of PAOD (100).  Endurance exercise training 
improves the utilization and extraction of oxygen from erythrocytes, influences blood 
viscosity, and raises pain thresholds (81; 82).  Aerobic exercise training also improved 
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endothelial function (11) increasing endothelial release of vaso-active factors that 
increase intrinsic control of resistance (11).  
The precise mechanisms by which aerobic exercise training induces arteriogenesis 
and angiogenesis are unknown, but in animal studies, by day 12 of an exercise training 
protocol, angiogenic processes are histologically evident (61; 62), especially in the low 
oxidative, less vascularized white gastrocnemius tissue, which is primarily Type IIB 
fibers, which exhibited the greatest increase in capillarity (62).  A single bout of acute 
aerobic exercise training has been shown to trigger immediate upregulation of VEGF 
mRNA (81; 82).  There also appears to be a decrease in muscle VEGF protein 
expression and a corresponding increase in VEGF protein in the surrounding interstitium 
(81; 82).  Furthermore, aerobically exercising muscles show increases in both VEGFR-1 
and VEGFR-2 mRNA expression (32).  Together, these studies suggest that VEGF and 
its receptors are important parts of the mechanism by which exercise promotes 
angiogenesis, but the exact upstream triggers and downstream targets of this pathway 
under these conditions remains unclear.   
Other angiogenic factors that may influence intrinsic aerobic exercise capacities 
response to ischemic challenge are angiopoietin 1 and 2 (Ang1 and Ang2) and nitric 
oxide (NO) (Figure 1.2).  These three factors are known to be key players in exercise 
induced and ischemia induced angiogenesis as well as the combination of both stressors 
(29; 32; 38; 62; 107).  The angiopoietins are important cytokines that assist in vascular 
development and remodeling (29).  Ang 1 promotes maturation and stabilization of 
vessels and is expressed widely throughout tissues, while Ang 2 displaces Ang 1 and 
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activates the Tie2 receptor.  The Tie2 receptor is expressed at sites of vascular 
remodeling.  Thus Ang1 dominance is associated with a stable vasculature, while Ang2 
dominance is associated with active angiogenesis.  In response to aerobic exercise 
training, Ang2 to Ang1 ratio was more affected in highly oxidative fibers compared to 
low oxidative fibers, suggesting that these Ang factors may have more pronounced 
effects on vascular remodeling in highly vascularized sections. 
NO can be increased with activation of VEGF receptors, VEGFR2 or kinase 
dependent receptor (KDR) (29).  The increase in NO production can be critical to VEGF 
signaling and the remodeling response of the skeletal muscle (29).  Training elevates 
endothelial nitric oxide synthase (eNOS) expression, one enzyme that controls NO 
production, and eNOS knockout mice show a requirement for NO in skeletal muscle 
angiogensis. Studies suggest that angiogenesis in response to aerobic exercise training 
may rely heavily on NO (29).  In summary, while there are a variety of factors that 
influence angiogenesis in response to exercise alone, ischemia alone, and the 
combination of both, there are likely pathways for which the importance of intrinsic 
aerobic exercise capacity on the angiogenic response to ischemia could be related, 
but as yet has not been established.  
Aerobic exercise training, in addition to its vascular and angiogenic alterations 
within ischemic tissue, has been found to increase long chain fatty acid (LCFA) 
availability and transport. Aerobic exercise training also appears to increase the enzymes 
of the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (1; 97). With these 
alterations, subjects with enhanced aerobic capacity can use more fat for energy 
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production at both the same absolute and at the same relative exercise intensities (41; 99). 
This is advantageous for any disease condition because these tissues maintain energy 
output under stressful conditions.  Aerobic exercise training also triggers a change in 
muscle fiber type from fast to slow.  In particular, fiber type changes characterizing 
aerobic endurance exercise training primarily shifts type IIB toward type IIA (75).  
Increased exercise intensities that has induce a more pronounce hypoxic event have been 
shown to force transitions beyond the fast fiber type population (75).  Fiber type 
phenotypic transitions occur due to a variety of influences, including changes in gene 
expression and altered transcription and translational activities.  However, an exact 
mechanism responsible for phenotypic transitions is still unknown.  Evidence suggests 
that Ca2+ and calcineurin may play an important role in the control of gene expression (75) 
(Figure 1.1) within skeletal muscle in response to exercise, but multiple pathways may 
exist. 
Aerobic exercise training is one treatment option that improves quality of life and 
tissue perfusion characteristics, presumably by inducing controlled, reversible demand 
ischemia, leading to increased capillary density (101).  Aerobic exercise training has 
been shown to increase capillary development within healthy skeletal muscle through the 
process of angiogenesis (61; 62; 81; 82; 107) that involves the vascular endothelial 
growth factor (VEGF) driven pathway (61; 62; 81; 82; 107) (Figure 1.2).  The potential 
involvement of NO, Ang1 or Ang2 has not been determined at this time, but there is 
strong evidence to suggest that VEGF cannot act independently.  The mechanisms by 
which aerobic exercise training improves intermittent claudication in PAOD patients 
remains unclear (92; 93).  Clinical data of PAOD shows that patients limited by 
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intermittent claudication who engage in any amount of weekly physical activity beyond 
light intensity have a lower mortality rate than their sedentary counterparts who perform 
either no physical activity or only light-intensity activities (30).  This study also found 
that the protective effect of physical activity persists even after adjusting for other 
predictors of mortality, including age and body mass index (BMI).  Thus, aerobic 
exercise training appears to induce adaptive remodeling within ischemic skeletal muscle, 
but these pathways and mechanisms of improvement are not well characterized.  
Aerobic exercise training appears to be a potent stimulus of angiogenesis through 
VEGF and other angiogenic growth factors that within skeletal muscle can alter capillary 
density and increase potential tissue perfusion.  In addition to vascular adaptive changes, 
aerobic exercise training influences skeletal muscle oxidative capacity through alterations 
in mitochondrial volume and enzymatic activity.  In addition to changes within the 
muscle fiber, aerobic exercise training also appears to have the capacity to induce muscle 
fiber phenotypic switches.  These adaptations, both vascular and metabolic, are 
mechanism that can provide protection against development of arterial insufficiency and 
in the event of ischemic disease may improve patient quality of life. 
Rat Model and Low and High Capacity Running Rats 
A model to investigate the contributions of intrinsic aerobic exercise capacity 
versus adaptations induced by aerobic exercise training has been developed.  Using a 
genetically heterogeneous outbred stock of N:NIH rats, two rat strains, low endurance 
running capacity (LCR) rats and high endurance running capacity (HCR) rats were 
developed by forced artificial selection, using a forced endurance treadmill running test 
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(51; 53).  Genetic variance among the population has been maximized by not selecting 
among brother and sisters.  At 10 weeks of age, rats undergo a protocol to estimate 
aerobic running capacity.  The rats complete a forced run treadmill protocol which 
allows for the highest and lowest running rats to be selected from each sex and randomly 
paired for mating.  Over several generations, two divergent rat strains have been 
produced such that by the 11th generation, a difference in running capacity of 347% was 
present (53; 105).  The difference can be translated to the LCR rats on average, as a 
decreased running capacity of 16 meters per generation, while the HCRs increased by an 
average of 41 meters per generation.  The divergence has further increased to a 
difference of 461% by the 21st generation (53; 105).  This animal model is valuable in 
the study of the interaction between aerobic capacity and chronic diseases because the 
differences observed in aerobic capacity between these strains is evident under sedentary 
conditions, which removes the conflicting effects of training adaptation due to daily 
exercise training (45; 97; 106).  
Previous work has demonstrated that these rat strains have different risk profiles 
for cardiovascular disease.  Wisloff et al. utilized rats from the 10th and 11th 
generations to measure differences in cardiovascular disease risk factors between the two 
phenotypes (106).  LCR rats were found to be more insulin resistant, with increased 
visceral adiposity to body weight ratio, higher serum free fatty acids, and increased blood 
pressure.  Noland et al. (72) in our laboratory utilized generation 13 rats to assess 
specific differences in fatty acid disposal by skeletal muscle as a function of intrinsic 
oxidative capacity under normal and high fat diet conditions.  The results confirmed 
basic characteristics of relative insulin resistance in the LCRs as reported previously by 
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Wisloff et al. (106), but in addition demonstrated differences between the phenotypes in 
adaptive responses to the stress of a high fat diet, suggesting possible differences between 
phenotypes in response to other environmental stresses other than high fat feeding, such 
as ischemia. 
Previous work in our lab utilized this model to investigate whether differences in 
intrinsic aerobic exercise capacity offered protection against acute ischemic reperfusion 
injury (AIRI) (unpublished data).  Findings from this study indicated that there were 
phenotypic differences in infarct size to AIRI when ischemic challenge is 15 minutes but 
these phenotypic differences disappear when ischemic challenge increases to 30 minutes. 
This data suggests the potential for intrinsic exercise capacity to influence the response of 
tissue to ischemic challenge, but if the challenge is too severe, intrinsic protective 
pathways in the HCR disappear.  Because intermittent claudication is not as a severe 
ischemic injury, it provides a model for investigating if the protective intrinsic ischemic 
pathways associated with the HCR phenotype are preserved. 
Goals of Current Study 
The purpose of this project is to gain a better understanding of the effect of intrinsic 
exercise capacity on the adaptive responses to ischemic disease.  Previous studies have 
found that the LCR phenotype has decreased capillary density when compared to the 
HCR counterparts (43; 105) and increased risk to disease (72; 97), this suggests that the 
LCR phenotype will have a decreased tolerance to a peripheral ischemic injury and 
demonstrate maladaptive responses from vascular and metabolic pathways.  We will 
test the hypothesis that the low aerobic endurance running capacity (LCR) 
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phenotype will show altered vascular and metabolic adaptive responses to 
peripheral arterial occlusion than the high aerobic endurance running capacity 
(HCR) phenotype. 
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Figure 1.1.  Proposed ischemia and aerobic exercise training induced changes in 
skeletal muscle 
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Figure 1.2.  Proposed aerobic exercise training induced pathway to increase 
capillarization 
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CHAPTER 2: METHODS 
Animal Strains.  40 LCR and 40 HCR generation 22 rats were obtained from Drs. 
Lauren Koch and Steven Britton at the University of Michigan.  Those authors have 
previously described the selection process of artificial selection(12; 52; 54).  Briefly, 
two-way forced artificial selective breeding was used to create low capacity runner (LCR) 
and high capacity runner (HCR) strains that were divergent for treadmill running capacity 
(run time to exhaustion on a graded treadmill exercise test).  The 13 lowest and 13 
highest running capacity rats of each sex were selected from the founder population 
(N:NIH stock) and randomly paired for mating.  At all other times, animals had no 
exercise other than spontaneous cage activity.  The only exposure to exercise for these 
animals was during the five day window at 10 weeks of age when they underwent the 
treadmill protocol to establish phenotype.  Once phenotyping was verified, animals were 
prepared for shipping at 14 weeks of age, or as soon after as weather conditions (airport 
tarmac temperatures < 85°F) permitted.  Once received by the Department of 
Comparative Medicine at ECU, the animals were maintained under mandatory quarantine 
for 10 weeks before they were released for study.  Therefore, all animals were at least 
24 weeks of age before they were available to be enrolled in a protocol.  Rats were 
provided standard rat chow and water ad libitum, and were kept on a 12 h light/ 12 h dark 
time schedule until sacrifice.  Animal procedures were conducted in accordance with 
American Physiological Society guidelines for the humane and safe use of animals, and 
all protocols involving animals used for these experiments were approved by the East 
Carolina University Animal Care and Use Committee. 
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Generation 22 animals were used in the current study.  The phenotypic characteristics 
(best run time, distance and body weight) for individual rats used in this study can be 
found in Tables 2.1 (LCR group) and 2.2 (HCR group).  Generation 22 LCRs averaged 
23.3 ± 0.155 minutes for best run time while the HCRs averaged 67.01 ± 0.285 minutes 
(Figure 2.1A).  The LCRs achieved an average best distance on this treadmill test of 
357.33 ± 3.29 meters while the HCRs performed an average best distance of 1759.76 ± 
12.32 meters (Figure 2.1B).  Similar to previous studies, animals in the cohort for these 
experiments differed significantly in their body weight at 10 weeks of age, with the LCRs 
weighing 332.23 ± 4.25 grams while the HCRs were averaging 242.84 ± 4.19 grams. 
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Table 2.1.  LCR generation 22 rat phenotypic characteristics. 
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Rat # Body 
Weight 
Run 
Time 
(min) 
Run 
Distance 
(m) 
Rat # Body 
Weight 
Run 
Time 
(min) 
Run 
Distance 
(m) 
22889 343.33 21.93 328.60 22952 338.67 23.20 354.40 
22850 314.33 21.93 328.60 22900 306.33 23.32 356.97 
22871 344.00 21.93 328.60 23107 319.33 23.32 356.97 
22912 334.00 21.97 329.30 22905 364.33 23.60 363.20 
22887 353.67 22.15 333.15 22807 313.33 23.68 365.03 
22839 283.67 22.20 334.20 22845 341.00 23.70 365.40 
23100 381.00 22.25 335.25 22954 345.33 23.85 368.70 
23106 313.00 22.25 335.25 22911 307.67 23.90 369.80 
22820 349.33 22.40 338.40 22922 273.00 23.97 371.27 
22864 335.67 22.43 339.10 22935 333.33 24.05 373.10 
22956 349.33 22.43 339.10 22934 303.67 24.32 378.97 
22938 327.00 22.53 341.20 22945 359.33 24.32 378.97 
22925 298.67 22.62 342.95 22937 328.00 24.38 380.43 
23108 328.33 22.68 344.35 22898 279.67 24.40 380.80 
22999-23195 403.67 22.73 345.40 22913 376.33 24.42 381.17 
22921 327.67 22.73 345.40 22906 362.00 24.58 384.83 
22978 336.67 22.90 348.90 22852-22980 346.33 24.72 387.77 
22851 356.67 23.05 351.10 22914 343.33 24.87 391.07 
22944 323.33 23.15 353.30 22806 277.33 25.03 393.77 
22946 347.00 23.15 353.30 22863 320.33 25.10 395.30 
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Table 2.2.  HCR generation 22 rat phenotypic characteristics. 
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Rat # Body 
Weight 
Run 
Time 
(min) 
Run 
Distance 
(m) 
Rat # Body 
Weight 
Run 
Time 
(min) 
Run 
Distance 
(m) 
13208 242.67 70.33 1905.00 13167 238.67 66.48 1736.78 
13108-13300 245.33 70.27 1902.00 13226 188.67 66.47 1736.07 
13117 253.67 69.72 1877.25 12978 287.67 66.30 1728.90 
12927 244.67 69.70 1876.50 12908 220.33 66.23 1726.03 
12951 284.33 69.52 1868.25 12994 257.33 66.18 1723.88 
13213 255.33 69.33 1860.00 13164 224.33 66.15 1722.45 
13148 217.33 69.10 1849.50 12974 232.33 65.92 1712.42 
13188 228.33 68.95 1843.80 13154 302.33 65.87 1710.27 
13165 229.33 68.60 1828.40 12966 160.33 65.75 1705.25 
12993 256.00 68.43 1821.07 12991 250.67 65.58 1698.08 
13239 268.67 68.35 1817.40 13189 221.00 65.45 1692.35 
13234 230.67 68.32 1815.93 13209 230.67 65.20 1681.60 
12998-13215 227.67 67.98 1801.27 13233 239.33 65.12 1678.02 
13129 248.00 67.93 1799.07 12928 266.33 65.08 1676.58 
13214 235.33 67.78 1792.47 12995 250.00 64.93 1671.20 
12917 258.67 67.73 1790.27 12992 267.67 64.73 1662.80 
13230 237.67 67.42 1776.33 12907 270.33 64.70 1661.40 
13191 217.33 67.35 1773.40 13241 247.67 64.57 1655.80 
13106 243.67 67.22 1767.53 13175 283.33 64.38 1648.10 
13210 225.00 66.78 1749.68 13254 225.00 64.37 1647.40 
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Figure 2.1.  Comparison of generation 22 best run time and distance.  A.  
Comparison of LCR and HCR best run times (min). LCR achieved a significantly less 
best time for forced treadmill run test compared to HCR (*, p<0.05).  B.  Comparison 
of LCR and HCR best run distance (meters). LCR performed significantly less meters 
during the forced treadmill run test compared to HCR (*, p<0.05). 
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Hind Limb Femoral Artery Occlusion.  Femoral artery occlusion was produced as 
outlined by Lloyd et al. (61; 62).  Briefly, rats were anesthetized with 90:10 
ketamine/xylazine solution (dosage 0.08-0.1ml mixture per100g body weight i.p.).  The 
fur was shaved from the inner thigh and the surgical sight was cleaned with Betadine and 
70% alcohol.  Utilizing a small incision, the right femoral artery was isolated and three 
ligatures of 3.0 surgical silk were placed to cause an ischemic condition in the 
downstream tissue.  One ligature was placed 5-6mm distal to the inguinal ligament, a 
second was placed on a collateral artery arising from the inguinal fat pat, and the third 
was placed 5-6 mm distal to the first ligature.  When all three ligatures were in place, 
the incision was closed in layers and the animal was given a Buprenex injection (dosage 
0.1ml mixture per 100g body weight i.p.) and placed on a warming blanket under a 
heating lamp to recover.  Once spontaneous movement and sternal recumbancy was 
observed, the animals were returned to their cages and returned to the animal facility.  
Animals were sacrificed at 7 (18 HCR and 18 LCR) or 14 days (10 HCR and 10 LCR) 
following placement of the ligatures. 
Microsphere Injections.  To determine relative bulk perfusion in ischemic and non 
ischemic muscles, colored tracer microspheres were utilized.  The underlying rationale 
for this technique is that microspheres, when injected into the left ventricle, will 
distribute in relative proportion to blood flow to any given region.  The size of the 
microsphere determines the anatomic vascular level at which the flow determination is 
made.  Typically, microspheres of between 10 and 20 µm in diameter are used, leading 
to first pass clearance of all injected microspheres at the capillary level.  It has been 
estimated that a typical microsphere injection occludes approximately 5% of a given 
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capillary bed, and that any capillary bed has 30-40% excess perfusion capacity.  
Therefore, as many as 6 different microsphere tracers may be injected before the 
procedure itself is expected to alter tissue perfusion patterns.  In the present studies, a 
maximum of two injections was performed.      
To perform the injections, a PE50 catheter was positioned in the left ventricle by 
retrograde advancement under continuous pressure guidance after insertion in the right 
carotid artery.  Proper positioning of the catheter in the left ventricle was determined by 
observing the characteristic transition from arterial pressure to left ventricular pressure 
values, and was verified postmortem by visual inspection of catheter tip placement in the 
left ventricle.  Yellow, and persimmon (15 um) Dye-Trak microspheres (Dye-Trak; 
Triton Technology, San Diego, CA) were dispersed by sonication and vortex mixing.  
The number of microspheres for any given color (mean diameter, 15um) injected into the 
left ventricle was about 900,000/0.3ml.  The microspheres were loaded into the catheter 
and given as a bolus injection followed by a flush of 0.5ml of saline.   
Microsphere injections were conducted on the day of euthanasia, 7 or 14 days 
following surgery to occlude the right femoral artery. Yellow microspheres were injected 
first as a control, which allowed comparison of flow between the non-ischemic left 
gastrocnemius muscle, and the right, post-occlusion gastrocnemius.  Following the first 
injection, the left femoral artery was ligated acutely, at similar locations to those used 
previously for the right femoral artery.  Immediately after ligation, the persimmon 
microspheres were injected.  Comparison of tracer densities obtained using this 
microsphere were used to determine the difference between native collateral flow 
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Microsphere Tissue Digestion and Recovery.  Unless otherwise indicated, all chemicals 
were obtained from Sigma-Aldrich (Sigma-Aldrich Inc., St. Louis, MO).  All reagent 
solutions were generated in-house following manufacturer’s directions for microsphere 
recovery and processing (Dye-Trak; Triton Technology, San Diego, CA).  Following the 
last injection of microspheres, gastrocnemius, soleus and plantaris muscles were excised 
and fixed in formalin for 1 hour.  Tissue was weighed (~1.0-2.0g) and then subjected to 
tissue digestion and processing as outlined by Dye-Trak.  Once a pellet of blanched 
microspheres and any remaining debris was obtained, the supernate solution was used for 
dye analysis.  Photometric absorption of each dye solution was determined by 
UV/Visible Spectrophotometer (wavelength 300-700nm with 1nm optical band width). 
The composite spectrum of each dye solution was resolved into the spectral of the single 
constituents by a matrix inversion technique, using formulas provided by the 
manufacturer for that purpose.  The absorption spectrum of each dye was measured 
separately from a control sample of each colored microsphere, and was used as a 
reference for the matrix inversion, determining the contribution of each color to the 
measured composite spectra at 440, 495, 545, 672 nm.  In the present study, the various 
vascular interventions precluded access to a reference withdrawal arterial blood sample 
that would have allowed final expression of the microsphere data in mls/min/gram tissue. 
Instead, the raw data, expressed as number of microspheres/gram tissue was used to 
report flow.  As a control to verify uniform distribution of blood flow, the right and left 
kidneys also were obtained and processed for microspheres.  Differences in microsphere 
distribution of greater than 7% between right and left kidney were used as a technical 
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criteria for ignoring all values obtained with that injection in that animal.  No data were 
excluded on that basis. 
High Frequency Stimulation.  As a gross functional test of differences between HCR 
and LCR phenotypes, demand ischemia was induced by direct electrical stimulation of 
the gastrocnemius muscle.  The pacing protocol was similar to that described by Keeton 
et al. (49).  Briefly, high frequency electrical stimulation was accomplished using a pair 
of wire electrodes, approximately 5 mm apart, inserted directly into the body of the 
gastrocnemius muscle.  Electrical impulses were delivered using a stimulator (Grass 
Instruments, Columbus OH) set to deliver repeated single pulses at a frequency of 5 Hz, 
200-400 mV, and a pulse duration of 1-ms duration.  Preliminary experiments were used 
to establish the threshold voltage for stimulation response (100-200 mV), and a 
stimulation frequency that would produce spontaneous exhaustion of muscle contraction.  
The electrical stimulation protocol lasted until the muscle failed to contract with enough 
force sufficient to cause a visible displacement of the foot.  Eight HCR and 8 LCR rats 
underwent high frequency pacing prior to hind limb femoral artery occlusion to establish 
baseline differences between the phenotypes, and 13 HCR and 14 LCR rats received 
pacing at the time of euthanasia to establish functional differences in the effective 
remodeling following femoral artery ligation.  
Rosenblatt Staining and Analysis.  Gastrocnemius muscles for each animal not used for 
microsphere studies of blood flow were cut in half and quickly frozen.  One half was 
placed in optimal cutting temperature (O.C.T.) compound while the other half was stored 
for protein isolation.  The muscle in the OCT was cut into transverse sections (thickness 
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10um) and underwent capillary staining as originally defined by Rosenblatt et al. (86).  
Briefly, Rosenblatt staining allows capillary visualization for subsequent photographs 
under 20 x magnification.  From the images, measurements were obtained in 5 fields per 
section, 50 myocytes/field, and in at least five separate sections, with care taken to avoid 
repeated sampling of the same field in sequential sections.  The following indices were 
measured: 1) number of capillaries around a fiber (NCAF), 2) the capillary to fiber ratio 
on an individual fiber basis (Cap/Fi), 3) the number of fibers sharing each capillary (share 
factor (SF)), and 4) capillary density (CD).   This stain also provides the ability to 
distinguish between different muscle fiber types.  Slow twitch fibers were counted and 
are presented as a percentage of the total fiber number. 
Fatty Acid Oxidation.  Red and mixed gastrocnemius tissues were quickly excised from 
anesthetized rats and placed in ice-cold isolation buffer (in mM: 100 KCl, 40 Tris·HCl, 10 
Tris base, 5 MgCl2·6H2O, 1 EDTA, and 1 ATP; pH 7.4).  Homogenates were prepared 
according to the methods of Kim et al. (50).  Briefly, 50–100 mg of tissue were 
thoroughly minced with scissors in 200 µl of buffer containing (in mM) 250 sucrose, 1 
EDTA, 10 Tris·HCl, and 2 ATP (pH 7.4), and then the buffer volume was brought up to 
yield a 20-fold (wt/vol) diluted sample.  This was transferred to a 3-ml Potter-Elvehjem 
glass homogenization vessel.  Muscle suspensions were homogenized on ice with a 
Teflon pestle at 10 passes over the course of 30 s at 1,200 rpm.  Homogenates were kept 
on ice until oxidation experiments were performed.  The liberation of 14CO2 from 
[1-14C]palmitate was used to assess mitochondrial fatty acid oxidation as previously 
described (21; 71).  Briefly, palmitate (200 µM) was bound to 0.5% BSA (final 
concentration) and brought up in reaction buffer to yield the following final 
37 
 
concentrations (in mM): 100 sucrose, 10 Tris·HCl, 10 KPO4, 100 KCl, 1 MgCl2·6H2O, 1 
L-carnitine, 0.1 malate, 2 ATP, 0.05 coenzyme A, and 1 dithiothreitol (pH 7.4).  
Aliquots (40 µl) of the appropriately diluted tissue homogenates were plated in 
quadruplicate in a modified 48-well cell culture plate (Costar, Cambridge, MA). A small 
groove was engineered between adjacent wells so that CO2 could freely diffuse between 
the incubation and trap wells.  Reactions were started by the addition of 160 µl reaction 
buffer.  Culture plates were sealed with parafilm and a siliconized rubber gasket and 
allowed to incubate in a shaking water bath at 37°C.  Reactions were terminated after 30 
min by addition of 100 µl of 70% perchloric acid to the incubation wells.  The 
incubation plate was transferred to an orbital shaker, and 14CO2 was trapped in 200 µl of 
1 N NaOH for 1 h at room temperature.  Radioactivity of CO2 was determined by liquid 
scintillation counting using 4 ml Uniscint BD (National Diagnostics, Atlanta, GA).  
Citrate Synthase Activity Assay.  Citrate synthase activity was determined using the 
method previously described methods (28; 71).  Briefly, 10ug homogenates were 
incubated in the presence of oxaloacetate, acetyl-coenzyme a, and 5,5’-dithiobis 
(2-nitrobenzoic acid (DTNB)).  Spectrophotometric detection of reduced DTNB as a 
wavelength of 412nm served as an index of enzyme activity. 
Western Blot.  Whole gastrocnemius muscle was homogenized in RIPA lysis buffer 
supplemented with a cocktail of protease and phosphatase inhibitors (P2714, P2850 and 
P5726, Sigma, St-Louis, MO), and centrifuged at 15,000 Xg for 25 min at 4°C.  The 
protein content in the supernatant was determined using BCA protein assay kit (# 23227, 
Pierce, Rockford, IL). Proteins were resolved by SDS-PAGE and transferred onto 
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nitrocellulose membranes (Bio-Rad, Hercules, CA).  The membranes were blocked 
overnight at 4°C in a blocking buffer made with Tris-buffered saline containing 0.1 % 
Tween 20 (TBS-T) and 4 % Bovine Serum albumin.  Subsequently, the membranes 
were incubated for 2h with the indicated antibody in the blocking buffer.  After 3 
washes of 5 min each with TBS-T, the membranes were incubated with an HRP 
conjugated secondary antibody for 1h, followed by 3 washes of 5 min each with TBS-T. 
The immunoreactive bands were visualized by enhance chemiluminescence (GE 
Healthcare, Piscataway, NJ) using the Typhoon Phosphorimager (Molecular Dynamics).  
RNA isolation, reverse transcriptase-PCR, and real-time PCR.   Total RNA was 
extracted from harvested gastrocnemius muscle using TriReagent (Sigma-Aldrich, USA) 
and cDNA was generated using the High Capacity cDNA kit from Applied Biosystems 
(Foster City, CA) following the manufacturer’s protocol. Real-time PCR was performed 
using specific primers (Table 2.3) (Invitrogen, La Jolla, CA) and SYBR Green mix 
(Applied Biosystems, Foster City, CA) following the manufacturer’s protocol and using 
GAPDH as the reference gene as CT values for this gene did not change with treatment. 
The Real-Time PCR detection system used was the ABI Prism 7900 sequence detection 
system (Applied Biosystems, Foster City, CA). LCR control samples were used for all 
data to be normalized with the ∆∆ct method. 
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Table 2.3.  Real Time PCR Primers sequences. 
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Primer Forward Sequence Reverse Sequence 
VEGF TTCAAGCCGTCCTGTGTGC TCCAGGGCTTCATCATTGC 
Flt-1 CCTCGCCAGAAGTCGTATGG CCTCGCCAGAAGTCGTATGG 
Ang1 AGATACAACAGAATGCGGTTCAAA TGAGACAAGAGGCTGGTTCCTAT 
Ang2 TGGCTGGGCAACGAGTTT TGGATCTTCAGCACGTAGCG 
eNOS GTGCTGGCATACAGAACCCA CCATGTGGAACAGACCCCA 
GAPDH GCTGAGTATGTCGTGGAGTC GTCAGATCCACAACGGATAC 
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Statistics.  Statistical analysis was performed using SPSS software (SPSS, Chicago, IL).  
Data are expressed as means ± SEM, and a p value <0.05 was considered statistically 
significant.  Student unpaired t-test were used to compare intrinsic differences between 
LCR and HCR run time to exhaustion and run distance.  For microsphere, real time PCR, 
and histology variables simple effects (LCR control vs LCR acute, LCR acute vs LCR 
7D, LCR 7D vs LCR 14D, HCR control vs HCR acute, HCR acute vs HCR 7D, HCR 7D 
vs HCR 14D, LCR control vs HCR control, LCR acute vs. HCR acute, and LCR 7Dvs 
HCR 7D, LCR14D vs HCR14D) were the comparisons of interest.  A mixed model 
analysis of variance (2x3 ANOVA, 2 groups (LCR and HCR) x 3 time points (control, 
acute, 7D for microsphere data and control, 7D, 14D for all other data sets)) was 
performed using SPSS on all variables between LCR and HCR control, seven day, and 14 
day endpoints.  Irrespective of a significant interaction, the simple effects defined were 
compared.  High frequency stimulation data was collected in two separate experiments 
so the post ligation data was analyzed with a student t-test as was the pre ligation data. A 
generalized linear model of variances using SPSS was performed on these two data sets 
with the intent to assess if there was a main effect for ischemia.  When there was a 
significant interaction, post hoc test were done with Bonferroni adjustment but 
irrespective of a significant interaction, the simple effects were compared without 
adjustments for multiple comparisons.  However p-values were less than 0.01 by simple 
effect analysis, which provides a level of confidence at least as powerful any adjustment 
for four comparisons would provide using Bonferroni. 
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CHAPTER 3:  EFFECTS OF HIND LIMB ISCHEMIC CHALLENGE ON 
VASCULAR ADAPTATIONS IN LOW AND HIGH CAPACITY RUNNING RATS 
Summary 
Untrained low endurance running capacity (LCR) rats have been found to have a higher 
incidence of risk factors for cardiovascular disease than their high endurance running 
capacity (HCR) counterparts.  Previous work with this model suggests that the LCR 
phenotype may have an inability to tolerate and generate a vascular response to ischemic 
stress imposed by unilateral hind limb femoral artery occlusion. We examined the levels 
of VEGF, Flt-2, eNOS, Ang1 and Ang2, capillary density, NCAF, Cap/Fib ratio, and SF 
under control conditions and following 7 and 14 days of unilateral hind limb femoral 
artery occlusion. Capillary density of the LCR rats was less and appeared to be less 
primed for angiogenesis compared to the HCR counterparts. Following occlusion, HCR 
rats generated an angiogenic response at 7 days while the LCRs generated a later 
angiogenic response that does not translate to alterations in capillary density. Therefore it 
appears that a lower intrinsic exercise capacity appears to be less tolerant of an ischemic 
injury but maintains the ability to generate a delayed angiogenic response.  
Introduction 
Peripheral artery occlusive disease (PAOD) is a major health problem affecting 
8-12 million Americans with limited treatment options (67).  The pathophysiology of 
PAOD is characterized by an impaired perfusion to the lower extremities.  Exercise 
training is one treatment option that improves quality of life and tissue perfusion 
characteristics through inducement of the ischemic tissue to increase capillary density 
(101) which is thought to increase surface area for exchange of oxygen and other 
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substances between capillary and muscle fibers (95).  Exercise training has been shown 
to increase capillary development within healthy skeletal muscle through the process of 
angiogenesis that involves the vascular endothelial growth factor (VEGF) driven pathway 
(15; 81; 82; 107).  The mechanisms by which exercise training improves intermittent 
claudication in PAOD patients remains unclear (92; 93).  Clinical data of PAOD shows 
that patients limited by intermittent claudication who engage in any amount of weekly 
physical activity beyond light intensity have a lower mortality rate than their sedentary 
counterparts who perform either no physical activity or only light-intensity activities (30), 
even after adjusting for other predictors of mortality, which include age, and body mass 
index (BMI).  Thus, exercise training appears to induce adaptive remodeling within 
ischemic skeletal muscle, but the pathways and mechanisms responsible for this 
remodeling not well characterized.  
Exercise is a complex stimulus with multifactoral outcomes, determined by at 
least two broad cohorts of genetic control.  One cohort establishes the innate aerobic 
exercise capacity or genetic component that each individual possesses irrespective of any 
subsequent training or activity, and the second genetic component establishes the pattern 
of responses to active exercise training.  It is estimated that up to 70% of the variation in 
exercise capacity are due to the genetic predisposition of an individual (9).  Many 
studies have focused on the active exercise training component, but even within these 
studies, there is a heterogeneous response in subjects to training protocols.  It is this 
finding that suggests the importance of investigating intrinsic exercise capacity and its 
impact on the response to ischemic stress.  
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Active exercise training in healthy individuals utilizes the ischemic stress of 
increased energy output with insufficient oxygen availability from inadequate perfusion 
to generate a remodeling stimulus for angiogenesis.  Vascular endothelial growth factor 
(VEGF) appears to be one of the signaling molecules that stimulates this angiogenic 
pathway (61; 81; 82).  There are three known VEGF receptors, VEGFR-1 (Fms-like 
tyrosine kinase 1 (FLT-1)), VEGFR-2 (Kinase insert domain-containing receptor (KDR) 
also known as fetal liver kinase (FLK-1)), and neuropilin-1 (NP-1) (61; 81; 82).  
VEGFR-1 appears to play an important role during development, while VEGFR-2 
appears to play an important role in mediating angiogenesis in the adult.  VEGFR-2 
appears to be the receptor that responds following exercise training and ischemic 
challenge independent of any active exercise (61; 62; 81).  It is not known whether these 
VEGF receptors contribute to differences in capillary density between animals that differ 
in their intrinsic exercise capacity.  
Other potential angiogenic factors that may influence intrinsic exercise capacity 
associated responses to ischemic challenge are angiopoietin 1 and 2 (Ang1 and Ang2) 
and nitric oxide (NO) (32; 38; 62; 107).  Both factors are known to be involved in 
exercise training induced angiogenesis and ischemia induced angiogenesis, as well as the 
combination of both stressors.  The angiopoietins are important cytokines that assist in 
vascular development and remodeling (29).  Ang 1 promotes maturation and 
stabilization of vessels and is expressed widely throughout tissues, whereas Ang 2 
competes with Ang 1 by displacing it from the activating Tie2 receptor. The Tie2 
receptor is expressed at sites of vascular remodeling.  Thus Ang1 dominance is 
associated with a stable vasculature while Ang2 dominance is associated with active 
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angiogenesis (29).  NO can be increased with VEGFR2 or KDR activation (29).  The 
increase in NO production can be critical to VEGF signaling and the remodeling response 
of the skeletal muscle.  Thus, there are a variety of factors that influence angiogenesis in 
response to exercise alone, ischemia alone, and the combination of both.  The influence 
of intrinsic exercise capacity on the ischemic expression and angiogenic response has not 
been studied and serves as the basis questioning the extent to which the gene profile that 
determine intrinsic aerobic exercise capacity phenotype also influence the basal and 
inducible expression of these important angiogenic factors. 
 Recently, Koch and Britton (51), have developed a model to investigate the role 
of intrinsic aerobic exercise capacity on responses and adaptations to chronic disease.  
Low aerobic capacity or low cardiovascular fitness, is a strong predictor of early 
mortality within PAOD patients (30; 92; 101) and recent studies with this model show 
that the low endurance running capacity phenotype (LCR) rats are more prone towards 
hepatic steatosis (97) and high fat diet induced insulin resistance (71).  These LCR rats 
from the 11th generation displayed a higher incidence of both cardiovascular and 
metabolic syndrome risk factors than the high endurance running capacity (HCR) 
rats(105).  All these studies demonstrate that different phenotypic backgrounds are 
associated with different susceptibility to disease that can be linked to skeletal muscle 
and its ability to utilize oxygen and meet energy demands.  These studies also show that 
this animal model is valuable in the study of the interaction between intrinsic exercise 
aerobic capacity and chronic disease. Previous studies have found that the LCR 
phenotype has decreased capillary density when compared to the HCR counterparts (44; 
106), which suggest that the LCR may have a decreased tolerance to this injury that 
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mimics PAOD, and studies of skeletal muscle responses to the stress of high fat feeding 
indicate that while the LCR’s are less tolerant, the inducible responses are largely intact 
(72).   
 The relationship between intrinsic aerobic capacity and the changes that occur in 
response to occlusion-induced ischemia in skeletal muscle is the focus of the present 
study.  Specifically, the hypothesis is that the low endurance aerobic exercise capacity 
phenotype will have an altered angiogenic adaptive response to ischemic stress compared 
to the high endurance aerobic exercise capacity phenotype.  To model ischemic stress 
similar to that seen in PAOD patients, we utilized an established unilateral hind limb 
femoral artery occlusion (61; 62).     
Results 
To provide a functional measurement for comparison between the phenotypes, 
high frequency electrical stimulation of the gastrocnemius muscle was performed prior 
and following ligation in two separate experiments.  Independent t-test were done on the 
data sets to assess if there was a significant difference between the phenotypes.  A 
generalized linear model of variances was done but did not show there was a significant 
interaction.  The t-test on the data set following ligation did show there was a significant 
difference with the LCR gastrocnemius muscle time to exhaustion different from the 
HCR (#, p <0.05, Figure 3.1).  The t-test on the data prior to ligation did not 
demonstrate differences between the phenotypes with an unstressed circulation.  The 
generalized linear model did not find when the data sets are assessed together a 
significant interaction.  A significant main effect for the ischemic condition was found 
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in both strains, such that following placement of the ligature on the femoral artery, both 
strains decreased the time to muscle exhaustion with pacing (*, p < 0.05, Figure 3.1).  
These data demonstrate that the injury produced a similar response in both phenotypes, 
but also showed that the ischemic injury uncovered phenotypic differences that were not 
present under baseline conditions. 
Microsphere injections and subsequent colored dye-extraction has been 
demonstrated to be an effective means to measure perfusion in skeletal muscle and other 
organs (108; 109).  The initial microsphere injection allowed for resting perfusion to be 
measured and was normalized for tissue weight.  This measurement provided 
information on resting, acute and seven day ischemic perfusion time-points to better 
characterize the underlying perfusion and effects ischemic stress placed on the 
phenotypes. There simple effect comparisons were the designed comparisons for this 
experiment.  The mixed model linear analysis of variance did not reveal a significant 
interaction.  Further analysis showed there was a significant main effect for phenotype 
and condition.  Not surprisingly, the condition main effect demonstrated that ligation of 
the artery produced a decrease in blood flow in both the LCR and HCR strains (* p < 
0.05, Figure 3.2).  The phenotypic main effect was evident in that the LCR animals had 
significantly less perfusion of the muscle at acute and seven day ischemic time-points, 
compared to the HCR animals.  Simple main effect comparisons between the LCR and 
HCR acute measurements demonstrated that the LCR had a significantly more severe loss 
of perfusion with occlusion (# p < 0.05, Figure 3.2).  Following seven days of ischemic 
challenge, the LCR continue to have less perfusion compared to the HCRs (#, p<0.05, 
Figure 3.3).  This data indicate that while both phenotypes altered tissue perfusion in 
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response to the hind limb ligature, the extent of perfusion deficit, and the pattern of 
recovery at seven days was significantly different as a function of the phenotype. 
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Figure 3.1.  Comparison of high frequency electrical stimulation time in LCR and HCR 
gastrocnemius muscles prior and following femoral artery ligation.  Both LCR and HCR 
animals significantly decreased time to exhaustion with ligature placement (*, p<0.05).  
LCR time to exhaustion following femoral artery ligation was significantly less compared 
to HCR time (#, p<0.05). 
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Figure 3.2.  Perfusion of muscles prior to, and following ligations of the femoral artery. 
LCR and HCR animals both significantly decreased perfusion following ligation (*, 
p<0.05), and LCR perfusion was significantly less than HCR (#, p<0.05). 
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Figure 3.3.  Perfusion of muscles immediately following, and 7 days after femoral 
artery ligation.  LCR animals had significantly lower perfusion both immediately and 
seven days after occlusion compared to HCR animals (#, p<0.05), suggesting phenotypic 
differences in either in pre-existing anatomic collateral blood vessels, or their control, and 
as well as phenotypic differences in the in the inducible response at seven days. 
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Figure 3.4.  Representative Rosenblatt stained gastrocnemius muscles of LCR and HCR 
animals.  A: LCR gastrocnemius muscle, B: HCR gastrocnemius muscles. 
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Figure 3.5.  Comparison of Real Time PCR results for VEGF (A) and Flt-1 (B) mRNA 
expression in control gastrocnemius muscles from LCR and HCR animals.  A:  LCR 
rats had significantly less VEGF mRNA expression compared to HCRs (*, p<0.05).  B: 
LCR rats did not significantly differ in mRNA expression of Flt-1 compared to HCRs. 
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Figure 3.6.  Comparison of Real Time PCR results for eNOS (A), Ang1 (B), and Ang2 
(C) mRNA expression in control gastrocnemius muscles from LCR and HCR animals.  
A: LCR rats had significantly less eNOS mRNA expression in control gastrocnemius 
muscle compared to HCRs (*, p<0.05).  B: LCR rats had significantly more Ang1 
mRNA expression compared to HCRs (*, p<0.05).  C: LCR rats had significantly less 
Ang2 mRNA expression compared to HCRs (*, p<0.05) 
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Figure 3.7.  Comparison of Real Time PCR results for VEGF (A) and Flt-1 (B) mRNA 
expression in control and 7 day (7D) post-ischemic gastrocnemius muscles from LCR 
and HCR animals.  A: Neither the LCR nor the HCR animals demonstrated significantly 
altered VEGF mRNA expression following 7D of ischemic challenge and baseline 
differences disappeared between the phenotypes.  B: Neither the LCR nor the HCR 
animals demonstrated significantly altered Flt-1 mRNA expression following 7D 
ischemic challenge. 
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Figure 3.8.  Comparison of Real Time PCR results for eNOS (A), Ang1 (B), and Ang2 
(C) mRNA expression in control and seven day (7D) post-ischemic gastrocnemius 
muscles, from LCR and HCR animals.  Significant differences between phenotypes in 
all three genes were present under control conditions (*, p< 0.05), but not seven days 
after ischemia, and none of the genes demonstrated an inducible response seven days 
after occlusion in either phenotype.  
64 
 
A. 
LC
R 
LC
R 7
D
HC
R 
HC
R 7
D
0.0
0.5
1.0
1.5
2.0
2.5
*
eN
O
S 
r
el
at
iv
e
 
ex
pr
es
si
o
n
 
le
v
el
 
B. 
LC
R 
LC
R 7
D
HC
R 
HC
R 7
D
0.0
0.5
1.0
1.5
*
An
g1
 
r
el
at
iv
e 
ex
pr
es
si
o
n
 
le
ve
l
 
C. 
LC
R 
LC
R 7
D
HC
R 
HC
R 7
D
0
1
2
3
*
An
g2
 
r
el
at
iv
e 
ex
pr
es
si
o
n
 
le
ve
l
 
65 
 
Figure 3.9.  Comparison of Real Time PCR results for VEGF (A) and Flt-1 (B) mRNA 
expression seven days (7D) and fourteen days (14D) after ischemia, in gastrocnemius 
muscle from LCR and HCR animals.  A:  LCR 14D ischemic gastrocnemius muscle 
significantly increased VEGF mRNA expression compared to 7D ischemic levels (*, 
p<0.05), and   LCR 14D VEGF mRNA expression was significantly greater than HCR 
14D ischemic gastrocnemius muscle (#, p<0.05).  B: LCR 14D ischemic gastrocnemius 
muscle significantly increased Flt-1 mRNA expression compared to 7D (*, p<0.05), and 
LCR 14D ischemic gastrocnemius muscle Flt-1 mRNA expression was significantly 
more than HCR 14D levels (#, p<0.05). 
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Figure 3.10.  Comparison of Real Time PCR results for eNOS (A), Ang1 (B), and Ang2 
(C) mRNA expression seven days (7D) and fourteen days (14D) after ischemic occlusion 
in gastrocnemius muscle from LCR and HCR animals.  A: LCR 14D ischemic 
gastrocnemius muscle eNOS mRNA expression significantly increased compared to 7D 
levels (*, p<0.05), and LCR 14D eNOS mRNA expression was significantly higher than 
the HCR 14D ischemic gastrocnemius muscle (#, p<0.05).  B: No statistically 
significant alterations in Ang1 mRNA expression level were observed between 
phenotypes or within the phenotypes at the different time points.  C: LCR 14D Ang2 
mRNA expression was significantly increased compared to 7D ischemic expression, but 
there were no statistically significant differences observed between the phenotypes at 
these time points. 
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Analysis of histology data in the present study generate results consistent with 
previously reports indicating that the LCR has reduced capillary density (CD) compared 
to the HCR in non-ischemic gastrocnemius muscle (11; 26) (*, p<0.05, Table 3.1) (*, 
p<0.05, Figure 3.11B).  In addition, these data demonstrate that there are significant 
interactions between phenotype and occlusion for CD, NCAF, and Cap/Fib.  There was 
no significant interaction detected for SF.  Simple effects were analyzed for SF and no 
significant differences were found.  Further analysis of the simple effects and 
conducting post hoc testing, using a Bonferroni adjustment, demonstrated that with 
respect to CD, the HCR control muscle is significantly lower than both the 7 day (7D) 
and 14 day (14D) measurements (#, p<0.05, Table 3.1)(#, p<0.05, Figure 3.14B), 
displaying an increase in capillary density seven and fourteen days after ischemia. 
Significant differences in capillary density (CD) between the phenotypes were present at 
all time points (*, p<0.05, Table 3.1) (LCR control vs HCR control, LCR 7D vs HCR 7D, 
and LCR 14D vs HCR 14D), and the LCR phenotype does not significantly increase the 
capillary density within the ischemic tissue. 
With respect to NCAF, there were no differences between phenotypes under 
control conditions.  Each phenotype increased NCAF significantly in response to 
ischemia, with the HCR greater at both the 7 day and 14 day time point measurements (#, 
p<0.05, Table 3.1)(#, p<0.05, Figure 3.15A), and the LCR significantly elevated only at 
the 14 day endpoint (#, p<0.05, Table 3.1) (#, p<0.05, Figure 3.15A).  The final NCAF 
values 14 days after ischemia were significantly greater in the LCR compared to the HCR 
animals (*, p<0.05, Table 3.1)(*, p<0.05, Figure 3.15A).   
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The capillary to fiber ratio on the individual fiber basis (Cap/Fib) demonstrated a 
significant increase at 7 days compared to control in the HCR (#, p<0,05, Table 3.1)(#, 
p<0.05, Figure 3.15B), but a similar increase above control levels was not seen in the 
LCR animal until 14 days(#, p<0.05, Table 3.1) (#, p<0.05, Figure 3.15B), at which point 
the LCR values were higher than the HCR animals (*, p<0.05, Table 3.1)(*, p<0.05, 
Figure 3.15B).    
The percentage of slow twitch muscle fibers in the mixed gastrocnemius muscles 
from the LCR and HCR animals was compared (Figure 3.13).  The LCR rats had a 
significantly lower percentage of slow twitch fibers in the control gastrocnemius muscle 
compared to the HCRs (*, p<0.05, Figure 3.13). With ischemic challenge, the LCR rats 
did not significantly alter the percentage of slow twitch muscle fibers (Figure 3.16), but 
the HCRs significantly increased the percentage of slow twitch muscle fibers between the 
7D and 14D ischemic time points ($, p<0,05, Figure 3.16). 
Assessment of mRNA for angiogenic markers was conducted on whole 
gastrocnemius muscle.  Under baseline conditions, relative expression of VEGF mRNA 
was significantly lower in the LCR rats compared to the HCRs (*, p<0.05, Figure 3.5), 
but VEGFR-1or Flt-1 mRNA expression were not different.  The LCR rats also had 
significantly less mRNA expression of eNOS and Ang2, and significantly more Ang1 (*, 
p<0.05, Figure 3.6), consistent with a more stable vasculature, or less remodeling 
potential, than the HCR counterpart.  With 7 days of ischemic challenge neither 
phenotype significantly altered mRNA expression (Figure 3.7, Figure 3.8), while at 14 
days, only the LCR animals demonstrated significant alterations, increases VEGF, Flt-1, 
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eNOS, Ang2 mRNA expression(*, p<0.05, Figure 3.8, Figure 3.9).  These increases of 
the LCR for VEGF, Flt-1, and eNOS at 14 days differed significantly from the HCR 
suggesting the LCR did generate an angiogenic response to ischemia. 
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Table 3.1.  Summary of skeletal muscle morphology and capillarization under control, 
and seven days (7D) and fourteen days (14D) after ischemia in gastrocnemius muscle 
from LCR and HCR animals. (*, p<0.05 compared to respective LCR value; #, p<0.05 
7D vs control values for the same variable within the phenotype; $, p<0.05 vs 14 day 7 
day values for the same variable within the phenotype). 
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 LCR HCR 
Area µm2   
  Non-Ischemic Gastrocnemius 4349.8 ± 281.3 2783.6 ± 236.3* 
  7 Day Ischemic Gastrocnemius 3031.4 ± 372.7# 2433.3 ± 369.8 
  14 Day Ischemic Gastrocnemius 4938.5 ± 788.6$ 2292.7 ± 622.2* 
Perimeter µm    
  Non-Ischemic Gastrocnemius 267.76 ±  8.57 211.85 ±   8.75 
  7 Day Ischemic Gastrocnemius 224.57 ±  9.44 200.72 ± 14.4 
  14 Day Ischemic Gastrocnemius 290.61 ± 26.95 190.29 ± 22.9 
Capillary Density, capillaries/mm2 (CD)   
  Non-Ischemic Gastrocnemius 417.81 ± 23.6 614.60 ±   57.5* 
  7 Day Ischemic Gastrocnemius 564.76 ± 40.5   918.54 ± 197.6*# 
  14 Day Ischemic Gastrocnemius 507.48 ± 54.2  1015.41 ± 174.9*# 
Capillary Contacts (NCAF)   
  Non-Ischemic Gastrocnemius 4.547 ± 0.220 4.280 ± 0.217 
  7 Day Ischemic Gastrocnemius 4.370 ± 0.584 5.170 ± 0.276* 
  14 Day Ischemic Gastrocnemius    6.220 ± 0.481*$ 5.210 ± 0.255*# 
Individual Capillary to Fiber Ratio (Cap/ Fib)   
  Non-Ischemic Gastrocnemius 1.662 ± 0.089 1.555 ± 0.073 
  7 Day Ischemic Gastrocnemius 1.603 ± 0.233  1.896 ± 0.149* 
  14 Day Ischemic Gastrocnemius    2.248 ± 0.183*$  1.852 ± 0.097# 
Share Factor (SF)   
  Non-Ischemic Gastrocnemius 2.896 ± 0.014 2.933 ± 0.062 
  7 Day Ischemic Gastrocnemius 2.890 ± 0.038 2.938 ± 0.069 
  14 Day Ischemic Gastrocnemius 2.935 ± 0.023 3.014 ± 0.015 
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Figure 3.11.  Comparison of fiber area (µm2) (A) and capillary density (capillaries/mm2) 
(B) in control gastrocnemius muscle from LCR and HCR. (*p<0.05 vs LCR value) 
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Figure 3.12.  Comparison of NCAF (A) and Cap/Fib ratio (B) in control gastrocnemius 
muscle from LCR and HCR animals.  Neither NCAF nor Cap/fiber ratio demonstrated 
significant differences between the phenotypes under control conditions. 
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Figure 3.13.  Comparison of the percentage of slow twitch fibers within control 
gastrocnemius muscle from LCR and HCR animals. (* p<0.05 vs. LCR). 
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Figure 3.14.  Comparison of fiber area (A) and capillary density (CD) (B) in control, 
seven day (7D) and fourteen day (14D) ischemic gastrocnemius muscle samples from 
LCR and HCR animals.  A: LCR fiber area was significantly less compared to HCR 
under control and 14D ischemic conditions (*, p<0.05).  LCR significantly decreased 
fiber area between control and 7D ischemia (#, p<0.05).  LCR significantly increased 
fiber area between 7D and 14D ischemic time points ($, p<0.05).  B: LCR demonstrated 
significantly less capillary density than HCR under control, 7D and 14D ischemic time 
points (*, p<0.05).  HCR significantly increased capillary density measurements from 
control at 7D and 14D ischemic time points (#, p<0.05). 
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Figure 3.15.  Comparison of NCAF (A) and Cap/Fib ratio (B) in control, seven day (7D) 
and (14D) ischemic gastrocnemius muscles from LCR and HCR animals.  A: NCAF in 
LCR significantly differed from HCR at the 14D ischemic time point (*. p<0.05).  LCR 
14D ischemia significantly increased from control (#, p<0.05) and 7D ischemia ($, 
p<0.05).  HCR 7D and 14D ischemia NCAF significantly increased above control 
NCAF (#, p<0.05).  B: Cap/Fib ratio in LCR significantly differed from HCR at the 14D 
ischemic time point (*. p<0.05).  LCR 14D ischemia Cap/Fib ratio significantly 
increased from control (#, p<0.05) and 7D ischemia Cap/fib ratio ($, p<0.05).  HCR 7D 
ischemia Cap/Fib ratio significantly differed from control Cap/Fib ratio (#, p<0.05).   
83 
 
A. 
LC
R
LC
R 7
D
LC
R 1
4D HC
R
HC
R 7
D
HC
R 1
4D
0
1
2
3
4
5
6
7
*#
##
$
N
CA
F
 
B. 
LC
R
LC
R 7
D
LC
R 1
4D HC
R
HC
R 7
D
HC
R 1
4D
0.0
0.5
1.0
1.5
2.0
2.5
*
#
#
$
Ca
p/
fib
 
ra
tio
 
84 
 
Figure 3.16.  Comparison of the percentage of slow twitch fibers within control, 7D, 
and 14D ischemic gastrocnemius muscle from LCR and HCR animals.  Percentage of 
LCR slow twitch fibers within control gastrocnemius muscle was significantly less 
compared to HCRs (*, p<0.05).  HCR significantly increased the percentage of slow 
twitch fibers between 7D and 14D ischemic time points ($, p<0.05). 
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Discussion 
The development of intermittent claudication is a major decrement to quality of 
life in patients (67; 94; 100; 103).  A mounting body of evidence suggests that exercise 
training can increase perfusion in ischemic tissue, improving quality of life and avoiding 
the necessity for surgical revascularization and other expensive therapies (67; 92; 100; 
101).  The majority of research on aerobic exercise training in PAOD patients has 
examined its effects upon vascular remodeling, including the mechanisms underlying 
changes in capillary density within the ischemic muscle (39; 61; 62; 80-82).  However, 
many patients with intermittent claudication are unable to exercise or participate in 
exercise protocols due to pain in the ischemic limb or arthritic problems in joints, and 
exercise studies do not always provide definitive remodeling within tissue.  Better 
understanding the genetic influences of intrinsic aerobic capacity and how endurance 
capacity affects the remodeling process within the vasculature in response to ischemic 
challenge, may help explain the variability in PAOD patients responses to aerobic 
exercise, and may provide new treatment options for individuals unable to participate in 
aerobic exercising protocols.  The goal of this study was to investigate whether rats with 
low intrinsic running capacity have different vasculogenic responses following peripheral 
arterial occlusion than rats with high intrinsic running capacity.  
The results of this study demonstrate that rats selectively bred, but not trained, for 
high endurance running capacity (HCR) differ in their response to ischemic stress in a 
model of PAOD compared to the low endurance running capacity (LCR) counterparts.  
These results provide strong evidence indicating that low endurance running capacity 
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confers increased risk for ischemic injury and is subject to delayed and less effective 
adaptive response to ischemic stress.  
Intrinsic differences  
LCR and HCR’s inherently differ in capillary density, with HCR rats having 
significantly higher capillary density than LCR rats (Figure 3.11B).  Under baseline 
conditions, the HCR strain are more primed for angiogenesis with a higher relative 
expression of mRNA for VEGF, eNOS, Ang2 and significantly less relative expression of 
Ang1 compared to the LCR strain (Figure 3.5 and 3.6).  These results are consistent 
with those found by Lloyd et al. (62) who showed similarly increased amounts of 
angiogenic markers undergoing aerobic exercise training protocols, except that in the 
present studies, these were intrinsic differences predicated on aerobic phenotype.  
Similar to the actively exercised rats, the HCRs appear to have an underlying increased 
angiogenic potential compared to the LCR phenotype under basal conditions.  As with 
capillary density, it is possible that the HCRs also have inherently more collateral vessels, 
allowing for redundant pathways to optimally sustain perfusion in peripheral tissues.  
The HCRs also appear to have a higher percentage of slow twitch fibers in their 
gastrocnemius muscle than their LCR counterpart (Figure 3.16).  It is suggested by 
Wisloff et al. (106) and unpublished data from our lab that the arteriolar vessels are more 
responsive to dilating factors in the HCRs compared to the LCRs.  These findings 
provide a potential explanation for the LCR strain’s incapacity to endure an ischemic 
challenge, demonstrated by a significantly more pronounced drop in tissue perfusion, as 
measured by microspheres, (Figure 3.2) in response to femoral artery ligation. 
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 LCR muscle cells have a significantly larger area compared to the HCR (Figure 
3.11A).  This finding is consistent with Howlett et al. (44) who found that mean 
cross-sectional area of the HCR fiber was 35% lower compared to the LCR.  This 
increased intrinsic size difference in muscle area may be due to the LCR having a larger 
body frame (72) and hence requiring larger cells to support their body type.  The HCR 
smaller fiber area is possibly due to its smaller body size (72).  The smaller fiber area in 
combination with intrinsic higher capillary density would potentially be an advantageous 
phenotype for ischemic conditions because it provides for decreased diffusion distance 
for nutrients.  It is these findings of smaller fiber area, more capillaries, and greater 
oxidative capacity in HCR rats that provides a potential mechanism to explain the 
inherent higher VO2max observed in these animals without aerobic exercise training. 
Increased capillary density (CD) (capillaries/mm2) has been shown to strongly 
correlate with increased skeletal muscle oxygen conductance in this model (44).  We 
now extend those observations by demonstrating that the HCRs may have inherently 
better protection for maintenance of tissue perfusion under ischemic conditions.  This 
was functionally evident with the prolonged time to exhaustion with high frequency 
electrical stimulation (Figure 3.1).  It appears that rats bred for higher endurance 
performance also select for smaller muscle fiber area and more capillaries which 
facilitates oxygen transport by decreasing the diffusion distance between the bloodstream 
and skeletal muscle.  On the other hand, the larger fibers with less capillary density of 
the LCR phenotype may be less tolerant of ischemic conditions. As perfusion decreases, 
this can cause increased diffusion distance of nutrients imposing a more potent ischemic 
stress within the muscle fibers. 
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Acute Changes to Ischemic Stress 
Microsphere perfusion indicates that remodeling occurs in the HCR animals in 
response to femoral artery occlusion (Figure 3.3).  The LCRs appeared to be under a 
more potent ischemic stress due to the occlusion as shown by the large initial drop in 
tissue perfusion.  The LCRs, despite this apparent increased ischemic pressure, do not 
demonstrate a measurable recovery in perfusion at seven days (Figure 3.3).  The HCRs 
initially lose less perfusion with acute arterial occlusion, presumably associated with 
better ischemic tolerance, and also expand perfusion in the post-ischemic tissue, 
consistent with anatomic remodeling, altered arteriolar/collateral tone favoring dilation, 
or both.  This flow preservation, suggesting an improved tolerance for ischemic stress 
by the HCR is further supported by the HCRs ability to maintain muscle fiber area 
(Figure 3.14A).  Furthermore, despite less ischemic pressure and negligible changes in 
fiber area, HCR rats showed a significant increase in capillary density at seven days.  
This increase in capillary density appears to be an angiogenically driven event, as 
suggested by increased capillary contacts (NCAF) and capillary to fiber (Cap/Fib) ratio in 
HCR rats.  However, the mRNA expression of angiogenic markers in the HCR did not 
significantly change.  This raises the possibility that in the HCR rats, the baseline levels 
of expression of the typical angiogenic growth factors were sufficient to drive this 
angiogenesis, and the response occurred without need for additional increases.  
Alternatively, it is possible that the HCR rats use a different set of angiogenic factors in 
the response to ischemia.  Conversely, the LCR animals did not generate a measurable 
change in perfusion following seven days of ischemic pressure (Figure 3.3).  These 
animals responded to seven days of femoral artery ligation with a significant loss of 
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muscle fiber area (Figure 3.14A) suggesting an attempt by the tissue to decrease diffusion 
distance for a more efficient exchange of nutrients, or a simple atrophic loss of muscle 
mass.  Despite this decrease in cell area, the LCR rats did not alter capillary density 
(CD), Cap/Fib ratio, or NCAF significantly from baseline levels.  The LCR rats did not 
show significant changes in mRNA expression for any of the angiogenic factors from the 
baseline to the 7D ischemic time point, suggesting that the LCR rats initially respond to 
seven days of ischemia was a loss in fiber area and no angiogenic response. 
Chronic ischemic stress adaptations 
Following 14 days of femoral artery occlusion, the HCRs continued to maintain 
fiber area (Figure 3.14A) but did not significantly alter any angiogenic markers from 
seven day levels (Figure 3.9 and Figure 3.10), suggesting that after fourteen days of 
ischemia, angiogenesis was no longer an active pathway within this phenotype and 
vascular remodeling processes had been completed.  This finding is consistent with 
Lloyd et al., who reported that ischemic induced angiogenesis typically alters mRNA 
within the 7-10 day window and return towards baseline levels near the 14 day time point 
(62).  Of particular interest in the present study was that HCRs appeared to increase the 
percentage of slow twitch fibers with 14 days of ischemia.  A fast to slow fiber switch is 
normally seen in response to aerobic exercise training and aging (75) but ischemia and 
unloading is typically associated with a slow to fast phenotypic shift.  This finding 
suggests a more rapid return of spontaneous activity in the HCR rats.  The HCR rats 
typically have increased cage activity and this cage activity may mimic aerobic exercise 
training.  Therefore, this fiber type switch observed at 14D may be an aerobic exercise 
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training response and not a response related to the ischemic injury.  The LCR rats also 
displayed a surprising finding, in that after an initial fiber loss at 7 days, muscle fiber area 
significantly increased again 14 days after femoral artery occlusion.  This finding was 
unexpected, but also may reflect the recovery of spontaneous activity.  LCRs do not 
exhibit any changes in body weight with femoral artery ligation. Thus, the possibility 
exists that these muscle cells at 7D ischemia decrease in fiber area in response to 
ischemic atrophy, but the decreased muscle mass was no longer sufficient to support the 
LCRs body weight, and increased mobility led to load dependent hypertrophy and 
re-expansion of the muscle fiber area, unrelated to the original occlusion. However, as a 
result of the hypertrophy, CD is maintained, and a relative ischemia may persist, leading 
to late/delayed angiogenesis, demonstrated by significant increases in NCAF and Cap/fib 
ratio, and significant increases in mRNA expression for VEGF, Flt-1, eNOS, and Ang2.  
Together, these findings suggest that a potent angiogenic drive remains inducible in the 
LCR phenotype.  This angiogenic stimulus may be in response to signals associated 
with hypertrophy of the LCR cells, but not with the occlusive stimulus, or may be 
occurring at fourteen days as a synergistic action of the loading stimulus in combination 
with ischemic drive within the tissue. 
This study suggests that LCR rats have an altered response to hind limb femoral 
artery occlusion compared to the HCR rats.  This altered response is partially due to the 
phenotypic differences under baseline conditions, including significantly less capillary 
density, less angiogenic factor potential, larger fiber area, and a smaller percentage of 
slow twitch muscle fibers within the gastrocnemius muscle in the LCR animals. With 
onset of occlusion, the LCRs also appear to have an altered inducible response compared 
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to the HCR. These alterations include fiber area initially decreasing, followed by a 
rebound to a larger area, a potent angiogenic upregulation at 14D ischemia, and no 
significant changes in the percentage of slow twitch muscle fibers.  These data suggest 
that low intrinsic aerobic capacity may have increased injury associated with ischemic 
disease and will generate an altered response that may require a combination ischemic 
challenge, and signaling from some other stress, such as increased mechanical loading of 
the muscle, to adequately stimulate vasculogenic responses. 
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CHAPTER 4:  EFFECTS OF HIND LIMB ISCHEMIC CHALLENGE ON 
METABOLIC ADAPTATIONS IN LOW AND HIGH CAPACITY RUNNING RATS 
Summary 
Untrained low endurance running capacity (LCR) rats have been found to have a higher 
incident of risk factors for cardiovascular disease than their high endurance running 
capacity (HCR) counterparts.  Previous work with this model suggests that the LCR 
phenotype may have an inability to tolerate a high fat diet, but it is unknown how this 
phenotype will metabolically adapt to stress imposed by unilateral hind limb femoral 
artery occlusion. We examined the levels of palmitate oxidation and citrate synthase 
activity under control conditions and following 7 and 14 days of unilateral hind limb 
femoral artery occlusion.  Palmitate oxidation and citrate synthase activity of the LCR 
rats was less under control compared to the HCR counterparts.  Due to their inherent 
advantage in palmitate oxidative capacity, HCR rats appear to have a delayed adaptive 
increase in red gastrocnemius palmitate oxidative capacity compared to the LCR 
phenotype.  Therefore these data suggest that animals with inherently lower aerobic 
exercise capacity also have lower oxidative capacity that probably limits the ability to 
tolerate ischemic stress.  Both strains maintain ischemia induced adaptations in 
oxidative capacity within red gastrocnemius muscle, but these changes are delayed 
suggesting differences in the regulation of changes in oxidative capacity. 
Introduction 
Peripheral artery occlusive disease (PAOD) is a form of ischemic disease, often 
with relatively limited treatment options. This disease is prominent as it affects 8-12 
million Americans (67). PAOD pathophysiology is characterized by an impaired 
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perfusion of the lower extremities leading to pain with movement secondary to demand 
induced ischemia, and results in decreased quality of life (30; 92; 93; 103).  Aerobic 
exercise training is an often employed treatment option for PAOD patients that has been 
associated with improved tissue perfusion and increased quality of life (92; 93).  
Aerobic exercise training also has been shown to be beneficial in other cardiovascular 
diseases, such as coronary heart disease and hypertension (11; 55; 58; 77; 79).  The 
benefits of active exercise training most often are attributed to induced increases in 
capillarization leading to increased oxygen delivery to tissues (31; 58), increased usage of 
fat as an energetic substrate (1; 21; 22; 92; 93), and increased mitochondrial respiratory 
capacity and energy production (41; 60; 92; 93).  However, active exercise training 
often produces a relatively heterogeneous response, despite well-controlled exercise 
protocols and well controlled study populations (2; 21; 30; 42; 60; 65; 92; 96).  In 
PAOD patients, and in animal models of PAOD, aerobic exercise training research has 
focused primarily on the changes in capillarization and perfusion, or the supply 
component of demand ischemia (39; 61; 62; 80-82; 92; 93).  The effects of decreased 
oxygen availability and the alterations that occur within skeletal muscle metabolic 
pathways of patient with PAOD are much less well studied.  The adaptive changes in 
distal tissue that could modify the demand components of ischemia, such as substrate 
utilization, have been studied much less extensively.  Research studies of ischemic 
stress on tissues outside of skeletal muscle suggest that adaptive mechanisms occur in 
metabolic enzymes, including citrate synthase expression and activity, and shifts in 
substrate preferences can occur.  While the benefits of active exercise regimens in the 
setting of cardiovascular diseases, including PAOD, is well-established (65; 67; 96), a 
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better understanding of distal tissue responses, and the factors influencing distal tissue 
metabolism, could provide the basis for additional treatment options in PAOD patients 
who are not candidates for revascularization.  
 The capacity for aerobic exercise has two components. The genetic component, or 
intrinsic aerobic exercise capacity, is estimated to explain up to 70% of the variation seen 
in the population (9), and presumably explains the heterogeneous responses to active 
exercise training protocols.  Active aerobic exercise, or the environmental element, is 
estimated to alter intrinsic aerobic exercise capacity, or VO2max, but maximum gains are 
limited (10-20%) (26; 104), further highlighting the importance of the intrinsic 
component on the overall aerobic capacity.  While responses to active exercise training 
have been characterized extensively, VO2 max is multifactoral, and is impossible to model 
by single gene gain or loss of function models.  Consequently, the contribution of the 
genetic, or intrinsic components of aerobic exercise capacity has been difficult to study 
effectively, and therefore, the importance of these intrinsic factors to the progression or 
attenuation of the pathophysiologic process such as PAOD are not well defined.  Based 
on the relative lack of understanding of the influence of environmental compared to 
genetic influences conferring reduced risk for cardiovascular disease by intrinsic aerobic 
exercise capacity, Koch and Britton have used forced artificial selection based on the 
endurance treadmill running phenotype, to develop a rat model to investigate the relative 
role of intrinsic aerobic exercise capacity, independent of an active exercise training 
effect (51).  Basic traits of these so-called high capacity and low capacity running 
strains (HCR and LCR) have now been characterized by other groups (83).  Our groups 
also has reported on the relationship of this intrinsic background to alter the response to 
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superimposed, non-exercise external stress, such as high fat feeding (71), to determine 
the potential benefit of the intrinsic aerobic capacity on responses and adaptations to 
elements of chronic disease (51).  Low endurance running capacity (LCR) rats display 
traits consistent with increased risk for cardiovascular and metabolic diseases in humans, 
such as insulin resistance (71) and endothelial dysfunction (unpublished data), while the 
high endurance running capacity (HCR) rats display characteristics consistent with 
decreased cardiovascular risk (106).  However, whether these traits actually translate to 
functional improvement in response to a superimposed cardiovascular insult has not been 
demonstrated.   
The definitive treatment option for PAOD is revascularization, either by surgical 
bypass or percutaneous methods (20; 66; 94; 103).  However, many patients are not 
candidates for this treatment option (20; 66; 94).  Therefore, understanding the distal 
tissue responses to ischemic stress becomes increasingly important as a basis for potential 
new treatment options in these individuals.  Active exercise, in the absence of ischemia, 
causes distal tissue remodeling, demonstrated with fiber type switching (102), changes in 
mitochondrial number, and changes in enzyme expression that ultimately produce 
increased respiratory capacity (1; 21; 91).  Similarly, ischemia alone, in the absence of 
active exercise, causes cardiac tissue to undergo phenotype switching of critical enzymes 
that regulate substrate utilization (73; 110).  Skeletal muscle under ischemic stress alone 
has demonstrated it also retains remodeling capabilities (14; 15).  Decreased oxygen 
availability induces skeletal muscle to alter fat oxidation for energy production (15; 87).  
Clearly, metabolic remodeling is a significant component of the tissue response to both 
active exercise and to ischemia, particularly with respect to fat metabolism.  However, it 
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is not clear whether the intrinsic capacity for exercise influences the tissue metabolic 
remodeling in response to ischemia.  Therefore, this study was designed to test the 
hypothesis that differences in intrinsic aerobic capacity, as established using the HCR and 
LCR rat strains, will alter the distal tissue remodeling of fat metabolism in response to 
peripheral arterial occlusion.  
Results 
Measurements of fatty acid oxidation. Measurements of fatty acid oxidative (FAO) 
capacity under control conditions in each of the phenotypes are shown in Figure 4.1.  
Under control conditions, LCR red gastrocnemius muscle did not differ from the HCRs, 
while LCR mixed gastrocnemius FAO capacity was significantly less than HCR  (*, p < 
0.05, Figure 4.1B).  This finding is consistent with control results previously reported 
our lab on FAO in response to high fat feeding using a cohort of generation 17 rats (71).  
In the present studies, when challenged with ischemia from a unilateral hind limb femoral 
artery occlusion, the LCR red gastrocnemius muscle generated an adaptive response by 
increasing FAO at both 7 and 14 days (p < 0.05, Figure 4.3A, 4.5A).  The HCR 
phenotype only generated an increase from control in FAO in the red gastrocnemius 
tissue at fourteen days (p < 0.05, Figure 4.5B), but not seven days.  Mixed 
gastrocnemius did not significantly change with ischemia in either phenotype and the 
differences observed at control disappeared.  
Citrate synthase activity measurements.  There were not measureable statistical 
differences in red gastrocnemius citrate synthase activity between the strains under 
control conditions (Figure 4.2A).  Mixed gastrocnemius citrate synthase activity was 
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higher in the HCR animals under control conditions (Figure 4.2B, *, p <0.05).  Both 
strains significantly increased citrate synthase activity from control to 14 days ischemia 
(Figure 4.6A and B, #, p<0.05) in both the red and mixed gastrocnemius tissue.
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Figure 4.1.  Comparison of palmitate oxidation capacity in control red (A) and mixed 
(B) gastrocnemius muscles from LCR and HCR animals.  A: No statistical differences 
were found between phenotypes in their control red gastrocnemius muscles.  B. LCR 
control mixed gastrocnemius muscle palmitate oxidative capacity was significantly less 
than the HCR (*, p<0.05). 
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Figure 4.2.  Comparison of citrate synthase activity in control red (A) and mixed (B) 
gastrocnemius muscle from LCR and HCR animals.  A:  There was no statistical 
significance observed between the phenotypes for citrate synthase activity in control red 
gastrocnemius muscle.  B:  LCR control mixed gastrocnemius muscle citrate synthase 
activity was significantly less compared to HCR (*, p<0.05) 
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Figure 4.3.  Comparison of palmitate oxidation capacity between control and 7D 
ischemic gastrocnemius muscle from LCR and HCR animals, by fiber type.  A: Red 
gastrocnemius muscle palmitate oxidation capacity increased significantly in LCR 7D 
from control (#, p<0.05), but no statistical differences were found between phenotypes.  
B. Mixed gastrocnemius muscle palmitate oxidation capacity was not significantly 
different in either phenotype after 7 days of ischemia. 
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Figure 4.4.  Comparison of citrate synthase activity between control and 7D ischemic 
gastrocnemius muscle from LCR and HCR animals, by fiber type.  A: Red 
gastrocnemius muscle citrate synthase activity was not significantly changed in either 
HCR or LCR animals after seven days of ischemia.  B.  Mixed gastrocnemius muscle 
citrate synthase activity was not significantly changed in either HCR or LCR animals 
following 7 days of ischemia. 
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Figure 4.5.  Comparison of palmitate oxidation capacity between 7D and 14D ischemic 
gastrocnemius muscle from LCR and HCR animals, by fiber type.  A:  Red 
gastrocnemius muscle palmitate oxidation capacity increased significantly in both LCR 
and HCR phenotypes 14 days after ischemia, compared to the 7 day levels (#, p<0.05), 
but no statistical differences were found between phenotypes.  B: Mixed gastrocnemius 
muscle palmitate oxidation capacity was not different in either phenotype at 14 following 
fourteen days of ischemia, relative to the seven day levels. 
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Figure 4.6.  Comparison of citrate synthase activity between 7D and 14D ischemic 
gastrocnemius muscle from LCR and HCR animals, by fiber type.  A: Red 
gastrocnemius muscle citrate synthase activity was increased significantly in LCR and 
HCR animals 14 days after ischemia, compared to seven day values (#, p<0.05), but the 
phenotypes were not different.  B: Mixed gastrocnemius muscle citrate synthase activity 
was increased only in the LCR animals 14 days after ischemia, relative to 7 day 
post-ischemic levels (#, p<0.05), but the phenotypes were not statistically different at 14 
days. 
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Discussion 
  Genetic selection based on an intrinsic aerobic capacity phenotype alone has shown 
differences at the level of skeletal muscle (44; 71; 106).  Functional improvements 
following superimposed cardiovascular insult, as a function of intrinsic aerobic capacity 
have been very difficult to study accurately until the recent development of a suitable 
model.  The creation of the HCR/LCR rat population and more recently, a similar mouse 
model has allowed for researchers to investigate if intrinsic aerobic exercise capacity 
confers an ability to adapt to stress and predisposes to disease (83).  Previous studies 
have linked low rates of mitochondrial oxidative capacity in skeletal muscle of the low 
performance phenotype as a critical component behind the predisposition to insulin 
resistance, obesity, and metabolic complications (71).  Thyfault et al. further expanded 
that low aerobic capacity was correlated with metabolic dysfunction within the liver (97).  
The present study utilized the model, with known differences in skeletal muscle oxidative 
capacity, to assess how these inherent differences would influence fatty acid oxidation 
following an ischemic insult mimicking PAOD.  
  Previously, Noland et al. (72) demonstrated inherent differences in fatty acid 
oxidation within the mixed gastrocnemius muscle for the HCR and LCR rats.  The HCR 
rats showed a heightened oxidative capacity in the gastrocnemius compared to the LCRs, 
but these differences were tissue specific and did not extend into the liver or heart.  Our 
data confirmed this finding of heighted oxidative capacity in the HCRs mixed 
gastrocnemius muscle compared to the LCRs, but further identified that even within 
skeletal muscle, these differences did not extend into a subset of red gastrocnemius 
muscle.  A novel finding of this study was that the HCR’s heightened oxidative capacity 
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within mixed gastrocnemius muscle was lost following both seven and fourteen days of 
ischemic challenge.  Another interesting finding was that although the baseline 
palmitate oxidative capacity within red gastrocnemius muscle did not significantly differ 
between the phenotypes, following 7 and 14 days of ischemic challenge the LCR 
demonstrated a significant increase in oxidative capacity. The HCRs demonstrated a 
significant increase in palmitate oxidative capacity only at fourteen days.  This finding 
suggests that skeletal muscles adapt to ischemia by increasing the palmitate oxidative 
capacity of their highly oxidative muscle fibers.  Due to their inherent advantage in 
palmitate oxidative capacity, HCR rats appear to have a delayed adaptive increase in red 
gastrocnemius palmitate oxidative capacity compared to the LCR phenotype.  
  Citrate synthase activity has routinely been used to assess mitochondrial volume 
density (41; 42; 60).  This enzyme also participates in the pathway of oxidative capacity 
leading to energy production within muscle cells.  Utilizing citrate synthase activity as a 
marker for mitochondrial volume/density in this model suggests that the HCR phenotype, 
under baseline conditions, may have significantly more mitochondrial volume/density 
than the LCR phenotype in the mixed gastrocnemius tissue.  This difference does not 
appear to extend to the red gastrocnemius tissue.  For both phenotypes, ischemia 
triggers increases in citrate synthase activity only at fourteen days in the mixed 
gastrocnemius muscle.  This differs from active exercise inductions in citrate synthase 
activity that can be induced with a single bout of an endurance exercise event (60).  
Thus, ischemic stress appears to trigger a delayed increased in citrate synthase activity 
when compared to active exercise and the increase in citrate synthase activity induced by 
ischemic challenge is influenced by intrinsic exercise capacity.  This finding suggests 
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there are other potential regulators of fatty acid oxidative capacity and citrate synthase 
activity with exercise training stimuli are not present under ischemic conditions. 
  It has been established previously that there is a shift in the predominant fuel within 
skeletal muscle from fat to carbohydrates under ischemic or exercise conditions (17).  
The ability of skeletal muscle to preserve fat utilization and spare glycogen is thought to 
be advantageous.  Increased aerobic capacity facilitates fatty acid oxidation through 
increased vascular supply, metabolic enzymes, and mitochondria number.  The higher 
baseline palmitate oxidative capacity and citrate synthase activity of the HCR rats should 
provide additional functional reserve and fatigue resistance in skeletal muscles stressed 
by decreased vascular supply.  Our data suggest that the HCR rats did not need higher 
palmitate oxidative capacity and citrate synthase activity as an adaptive response to 
ischemia in the first seven days after ischemic occlusion.  Conversely, having lower 
palmitate oxidative capacity and citrate synthase activity, as seen with the LCR 
phenotype likely was disadvantageous in first seven days after ischemia, requiring an 
immediate metabolic adaptive response to sustain tissue viability, due to lack of intrinsic 
reserve capability.  
  In summary, these data suggest that animals with inherently lower aerobic exercise 
capacity also have lower oxidative capacity that probably limits the ability to tolerate 
ischemic stress.  Alternatively, the higher aerobic exercise capacity with higher 
oxidative capacity provides short-term protection against ischemic stress.  Both strains 
maintain ischemia induced adaptations in oxidative capacity within red gastrocnemius 
muscle, but these changes are delayed in comparison to those triggered by active exercise, 
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suggesting differences in the regulation of changes in oxidative capacity triggered by 
ischemia versus active aerobic exercise.   
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CHAPTER 5:  CONCLUSIONS 
 Aerobic exercise capacity influences an individual’s quality of life and 
susceptibility to disease.  A mounting body of evidence suggests that individuals with 
low aerobic capacity have increased morbidity and mortality and are at higher risk for 
cardiovascular diseases.  Furthermore, a high aerobic capacity appears to have 
protective effects against metabolic disorders and cardiovascular disease.  The extent to 
which the protection against metabolic and cardiovascular diseases is attributable to the 
intrinsic aerobic capacity, versus active exercise training, is not well understood.  
Therefore, the goal of this dissertation was to examine the effects of inherent differences 
in aerobic capacity on response to ischemic stress.  Our hypothesis was that the low 
aerobic endurance running capacity (LCR) phenotype will show altered vascular 
and metabolic adaptive responses to peripheral arterial occlusion when compared to 
the high aerobic endurance running capacity (HCR) phenotype. 
  The results indicate that the hypothesis was correct: the LCR animals did differ 
from the HCR animals in both the vascular and the metabolic adaptive responses to 
peripheral arterial occlusion.  The different vascular responses were first demonstrated 
when control and seven day time point were compared.  The HCR rat’s adaptive 
responses primarily occurred in this time frame, while the vast majority of changes in the 
LCR occurred within the seven to fourteen day time frame.  In addition, it is speculated 
that the eventual response that did occur in the LCR may have been due to skeletal 
muscle signals arising from an overload response from the initial loss of muscle fiber area 
that rebounded by the fourteen day time point, rather than a direct response to tissue 
ischemia signals alone.  With respect to the metabolic adaptive responses within the 
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muscle fibers, these data also supports the hypothesis that there was a different response 
between the phenotypes.  The LCR animals increased palmitate oxidative capacity of 
the red gastrocnemius muscle at seven days while the HCR’s were not changed at this 
time point.  Taken together, these data demonstrates that intrinsic exercise capacity 
influences the adaptive responses following ischemic injury and perhaps the progression 
of ischemic disease.   
  There are three possible explanations for the differences in the LCR and HCR 
responses to peripheral arterial occlusion.  The first explanation is that because of their 
genetic endowment, the HCR rats have less need to adapt to arterial occlusion that the 
LCR rats.  Thus, our experimental manipulation of unilateral hind limb femoral artery 
occlusion does not stress the HCR rats to the same extent as this manipulation stresses the 
LCR rats.  Supporting evidence for such a postulate can be seen in the perfusion data 
obtained with microspheres (Figure 3.2).  The LCR rats endured a more significant loss 
of perfusion after femoral artery occlusion, supporting the explanation that this same 
manipulation induced a different injury within the phenotypes due to the genetic 
endowment.  Although each muscle in each phenotype was paced to exhaustion 
following occlusion to normalize the initial ischemic stresses, it is likely that any signals 
arising from that stress were more completely eliminated as the HCRs recovered to a 
higher post-ischemic flow.  In addition, the present study has shown that HCR rats have 
higher capillary density (Figure 3.11), significantly higher expression of pro-angiogenic 
growth factors (Figure 3.5, Figure 3.6), a higher percentage of slow twitch muscle fibers 
(Figure 3.13) and increased oxidative capacity, with both increased palmitate oxidative 
capacity (Figure 4.1) and citrate synthase activity (Figure 4.2) within the mixed 
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gastrocnemius muscle compared to the LCR rats.  Because of these inherent advantages, 
it is likely that arterial occlusion produced less ischemic stress in the HCR animals than 
the LCRs, and consequently induced less robust changes in angiogenic markers NCAF 
and Cap/Fib ratio (Figure 3.12 and Figure 3.15).  This depressed ischemic drive in the 
HCRs did not induce significant changes with angiogenic growth factors (Figure 
3.7-Figure 3.10).  With respect to metabolic endpoints, the ischemic stimulus appeared 
to be better tolerated within the HCR so that there were no significant changes in 
oxidative capacity between the control and seven day time point (Figure 4.3 and Figure 
4.4).  Taken together, there is a strong argument that the differences between the 
phenotypes in their adaptive responses to peripheral arterial occlusion is determined by 
the inherent differences that exist due to the genetic endowment. 
  A second possible explanation for the differences in adaption between the 
phenotypes is that the two groups adapt in the same way, but the LCR response is 
attenuated due to poor intrinsic aerobic capacity.  This scenario is supported by the data 
showing that both the LCR and HCR animals responded with increases in NCAF and 
Cap/Fib ratio (Figures 3.12 and Figure 3.15), but the LCR response did not occur until 
the fourteen day time point (Figure 3.15) whereas the HCR group demonstrated increases 
in these values at the seven day time point (Figure 3.12).  In the metabolic adaptive 
responses, both phenotypes responded with increased palmitate oxidative capacity and 
citrate synthase activity in the red gastrocnemius muscle at the fourteen day time point 
(Figure 4.5 and Figure 4.6), but the LCR also had to increase palmitate oxidation at an 
earlier (Figure 4.3) time point.  These data support the explanation that the adaptive 
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responses employed by both phenotypes are similar but the timing of the response is the 
component that is influenced by inherent aerobic exercise capacity. 
  A third possible explanation is that the HCR and LCR phenotypes utilize different 
mechanism to adapt to the peripheral arterial occlusion.  This conclusion is supported by 
the fact that the HCR rats changed capillary density but the LCR rats did not (Figure 
3.14).  Furthermore, the HCR phenotype adapted to ischemia in the gastrocnemius 
muscle by increasing the percentage of slow twitch fibers (Figure 3.16), as if there rats 
were undergoing exercise training, but the LCR muscle does not demonstrate significant 
fiber type switching under these circumstances.  The LCR animals increased NCAF and 
Cap/ Fib ratio at fourteen days after occlusion (Figure 3.15), but this increase may be due 
to an overload stimulus and not the ischemic stimulus.  These data support the 
explanation that difference in adaptive responses of the two phenotypes in their response 
to peripheral artery occlusion may be due to different mechanism and pathways.  
Therefore, intrinsic aerobic capacity may respond to the same stimulus with different 
mechanistic adaptive responses determined in part by the same gene profiles that 
establish intrinsic aerobic running capacity. 
  The present study has established that intrinsic aerobic capacity influences skeletal 
muscle capillary density, oxidative capacity, and muscle fiber type composition.  We 
have also shown that intrinsic aerobic capacity influences adaptive responses to 
peripheral arterial occlusion.  The high intrinsic aerobic capacity phenotype responds by 
changing capillary density in the gastrocnemius muscle within seven days.  This 
phenotype makes no significant changes in oxidative capacity within the seven day time 
period, but eventually increases the percentage of slow twitch fibers in the muscle.  
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Therefore, it may be suggested that this phenotype relies primarily on early vascular 
adaptive changes to respond to ischemic injury, and with chronic stimuli, can expand 
adaptive responses with manipulation of muscle fiber composition and oxidative 
capacity. 
  In contrast, the low intrinsic aerobic capacity phenotype adapts to peripheral arterial 
occlusion by increasing production of angiogenic growth factors and skeletal muscle 
oxidative capacity.  However, this phenotype’s vascular adaptive responses appear to be 
delayed and may be induced by overload stimuli rather than ischemic stimuli.  Therefore, 
it appears that this phenotype is more dependent on changes in oxidative capacity until 
the loss of muscle fiber area reaches threshold to stimulate a hypertrophic response.  It is 
then this hypertrophic response that induces, or at least augments, angiogenic changes 
within skeletal muscle leading to increased NCAF and Cap/Fib ratio but this change in 
muscle fiber area prevents significant changes in capillary density.    
Future Directions 
   Research has shown that active aerobic exercise can also increase capillary 
density and oxidative capacity within skeletal muscle.  One future avenue of research 
might be to determine the relative effect of superimposing active aerobic exercise training 
on low and high intrinsic aerobic capacity phenotypes to assess the impact of active 
exercise on each phenotype’s adaptive responses to occlusive ischemia.  The results 
may shed light on how much of the adaptive response is intrinsically determined and 
whether or not the response is alterable.  Another direction might be to explore the 
interaction between multiple environmental stresses, such as both active such as insulin 
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resistance and occlusive ischemia, to determine the extent to which the phenotypic 
differences are altered similarly by multiple forms of tissue stress. 
  There are numerous global ideas for future directions but based upon the current 
data, it appears there are more unanswered questions associated with the metabolic 
responses compared to the vascular responses between the phenotypes.  Due to this 
circumstance, more focused research on the intrinsic differences as well as the adaptive 
metabolic responses to ischemia may better explain the changes in palmitate oxidation 
and citrate synthase activity observed between the phenotypes. 
  This study demonstrates that intrinsic aerobic exercise capacity influences the 
response to ischemic stress.  The findings with palmitate oxidative capacity and citrate 
synthase activity demonstrate the complexity of skeletal muscle metabolism.  Citrate 
synthase, an enzyme in the TCA cycle, has been studied routinely to assess oxidative 
capacity and mitochondrial volume.  The present studies demonstrate that changes in 
citrate synthase activity do not correlate with changes in palmitate oxidation, at least in 
post-ischemic skeletal muscle.  There are other possible regulators, in addition to citrate 
synthase, that may explain changes in lipid oxidation, and there are additional enzymes 
that may expand our knowledge of changes in glucose utilization.  Regulation of lipid 
oxidation appears to be regulated by peroxisome proliferation activated receptors (PPAR) 
(68), in particular, PPARα and PPAR gamma coactivator-1 alpha (PGC-1α).  Both of 
these factors are potential candidates for critical regulators of skeletal muscle lipid 
metabolism, due to their influence to induce transcription of pyruvate dehydrogenase 
kinase-4 (PDK4), carnitine palmitoyltransferase-1 (CPT-1), and uncoupling protein 3 
(UCP3)(27; 56; 68).  These three enzymes are associated with increased fatty acid beta 
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oxidation (56; 68).  With respect to ischemia, when tissue should decrease reliance on 
fatty acid oxidation, it is predicted that the tissues would decrease PPARα and PGC-1α 
influences.  However, in the kidney, another tissue that relies primarily on fatty acid 
oxidation for energy, pretreatment with PPARα and PGC-1α restored expression and 
activity of fatty acid oxidation enzymes, which accounted for protective affects against 
acute renal failure (78).  These data support the suggestion that ischemia should reduce 
expression of PPARα and PGC-1α (78) but also indicates that maintenance or 
supplemental therapy with these ligands can potentially provide protection against 
ischemic injury.  In addition, PGC-1α has emerged as a critical mediator in other 
signaling pathways including those driving mitochondrial biogenesis, angiogenesis, and 
fiber composition (3).  It appears that PGC-1 may have a more vital role in muscle 
adaption to aerobic exercise training and pathological conditions such as cachexia, 
dystrophy, and PAOD (3). 
  PDK4 has been shown to play a critical role in the partitioning of substrates toward 
lipid or carbohydrate oxidation (76).  This enzyme performs this regulatory role with its 
ability to phosphorylate pyruvate dehydrogenase (PDH), the complex enzyme that 
catalyzes the conversion of pyruvate to acetyl-CoA(76).  Upon PDH phosphorylation, 
this enzyme is less active and glucose oxidation decreases within the tissue and an 
increased reliance on fatty acid oxidation.  Therefore, an increase in PDK4 would be 
associated with an increase in fatty acid oxidation and less reliance on glucose oxidation 
(76).  In relation to ischemia, it would be suggested that this enzyme in addition to 
PPARα and PGC-1α should decrease to suppress the reliance on fatty acid oxidation. 
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  PDH is the final step that commits nutrient carbons to enter the tricarboxylic acid 
(TCA) cycle or fatty acid synthesis (16). This enzyme is carefully regulated through 
phosphorylation and dephosphorylation (27; 59; 76).  With phosphorylation (PPDH), 
PDH activity decreases, causing decreased pyruvate conversion to acetyl-CoA.  Within 
the muscle, P-PDH is associated with a substrate preference for fatty acid utilization (27; 
59; 76).  This enzyme has primarily been studied in relation to high fat diets and obesity.  
Little is understood in skeletal muscle about the changes in this enzyme with ischemia.  
In the heart, myocardial substrate metabolism during ischemia is dependent upon the 
severity of ischemia.  A very severe reduction of blood flow can decrease substrate flux 
through PDH.  When perfusion is only partially reduced, or the ischemia is less severe, 
there is an increase in the rate of glycolysis and lactate uptake and a corresponding 
decrease in fatty acid oxidation (16).  It has been demonstrated that keeping PDH 
activity high and reducing the pyruvate conversion to lactate during ischemia is beneficial 
for cardiac cells as it reduces the acidification of the intracellular compartment (16).  As 
preliminary data for future studies, and to determine other potential stimuli for citrate 
synthase activity, we were interested in exploring whether changes in PDH would 
identify whether ischemic skeletal muscle was shifting substrate preference towards 
increased glucose oxidation, and differed by phenotype.  P-PDH and PDH protein 
expression were compared by western blot in control, 7D and 14D ischemic 
gastrocnemius muscle from LCR and HCR animals (Figure 5.1).  However, these data 
did not demonstrate a significant difference in PDH activity between phenotypes nor 
between ischemic time points.  These data suggest that there is not a difference between 
the phenotypes in their ability to regulate PDH enzyme activity and thus substrate 
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preference.  However, there is a potential trend that the LCR animals, under control 
conditions, may rely more on lipid oxidation than the HCR, as evidence by an increased 
P-PDH/PDH.  This data does suggest that more studies are necessary to more 
completely determine the role phenotypic determinants in other critical oxidative 
enzymes and whether there is a difference in substrate preference.  Ultimately, once 
more complete characterization is completed, systematic analysis of the specific genes 
that might explain the phenotypic responses to ischemia might be worthwhile, but more 
likely, studies such as the present serve to highlight the highly integrated responses to 
complex stressors, and that phenotypic profiling might be a more reliable means by 
which to capture the overall characteristics of these multifactoral responses. 
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Figure 5.1.  Comparison of P-PDH and PDH protein expression in LCR and HCR 
control, 7D and 14D ischemic gastrocnemius muscle.  A.  Representative blots of 
PPHD and PDH.  B.  P-PDH/PDH ratio. 
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Responsible Conduct of Research 
The ECU Research Ethics Oversight Committee oversees all research compliance 
activities of the University under the direction of the Vice Chancellor for Research, 
Economic Development, and Community Engagement. The committee reviews, approves, 
and resolves conflicts of interest issues and reviews and investigates cases of scientific 
misconduct for individual faculty and the University. A copy of policy regarding 
scientific ethics and misconduct (Part VII section VI of the ECU Faculty Manual) is 
given to each faculty member upon employment. This policy is updated regularly on the 
ECU web site. The University’s “Policy and Procedures on ethics in Research and 
Creative Activity” constitutes institutional efforts to promote responsibility by faculty, 
staff, post doctoral students, and students:  “to seek honestly and to promulgate ethically 
the truth in all phases of work.” The Policy provides, among other things, a list of 
principles to which the University subscribes in its research activities, and procedures for 
reporting, investigating, and determining penalties for unethical research activities (Part 7 
(VI)). 
The Bioethics Center, a joint program of BSOM and PCMH, provides educational 
opportunities for faculty, students, physicians, and hospital staff and supports the efforts 
of hospital committees charged to address ethical issues, including those dealing with 
research. The center sponsors bioethics conferences, workshops, and lectures and is 
staffed by faculty of the Department of Medical Humanities. The University’s “Principles 
and Policy for the Protection of Human Subjects of Research” establishes “responsible 
for protecting the rights and welfare of individuals who act as subjects for research 
conducted by its {principle investigators].” The Policy provides a Statement of Ethical 
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Principles and implements these Principles through the University Medical Center 
Institutional Review Board (Part 7(IV)). 
The University and Medical Center Institutional Review Board (UMCIRB) reviews and 
approves of any research, including clinical trials, involving the use of human subjects. 
The board protects the rights and welfare of human subjects engaged in research at 
BSOM, PCMH and its affiliates, and ECU, and in research conducted elsewhere by 
representatives of the University in connection with their responsibilities. 
The University’s Policy on:  “Animal Care and Use in Research and Instruction” 
becomes another instance of institutional efforts to ensure that “animals used in research 
and teaching will receive humane treatment at all times,” and to comply fully with 
applicable federal laws and regulations. The Policy provides specific responsibilities 
required by faculty members who conduct or supervise the conduct of animal 
experimentation. The Policy, moreover, establishes the Animal Care and Use Committee 
with the authority formally to monitor the care and use of vertebrate animals (Part 7(V)). 
Statement on the Care and Use of Animals in Research 
All animal research at East Carolina University meets the requirements and guidelines of 
the NIH Officer of Animal Care and Use. The animal facilities at East Carolina 
University are managed under the direction of the Department of Comparative Medicine 
and are AALAC and IACUC accredited. 
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